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              Understanding and studying the normal bone growth and development is causal.   
Bone and cartilage tissue provide in addition to their mechanical support, they provide a 
protection for vital organs such as heart, lung and brain. Longitudinal growth is regulated 
by the activity of chondrocytes in the epiphyseal growth plates of long bones. Many 
hormones and growth factors are involved in the regulation of this process. Among these, 
sex steroids are of crucial importance, especially during puberty. 
In long bones, endochondral bone formation occurs at the growth plate, a region 
of developing cartilage located between the epiphysis and the metaphysic. The process of 
endochondral ossification is regulated in part by sex steroid hormones. Androgens 
stimulate endochondral bone growth and elongation, while estrogen is known to suppress 
longitudinal bone growth and accelerate growth plate closure. Studies using rat 
costochondral growth plate chondrocytes as a model show that the effects of 17β-
estradiol (E2) on apoptosis are found in both male and female cells and the same 
mechanism is involved. In contrast, E2 causes rapid activation of PKC in female cells but 
not in male cells. Dihydroxytestosterone (DHT) also has direct effects on growth plate 
chondrocytes, increasing matrix synthesis including sulfated glycosaminoglycan 
production, and enhancing cell maturation by increasing alkaline phosphatase enzymatic 
activity.  
            Short stature and abnormally slow increase in height is one of the main reasons 
for referral to endocrinologist. Excessive growth and abnormally tall is also a problem, 
especially because it increase risk for the trunk abnormalities. Furthermore until now a 
 xii 
few growth-promoting therapies are available for clinical use. Therefore future therapies 
for treating the growth disorders are essential.  
            The overall goal of this project is to investigate the sexual-dimorphic effect of the 
sex steroid hormone in rat growth plate chondrocytes, the cellular signaling pathways 
mediating these actions, and their physiological role. The information gleaned from this 
study will provide new information about the role of sex steroid hormones in 
chondrogenesis and has implications in the development of new therapies for the 
treatment of bone fracture healing, and growth plate disorders. The central hypothesis 
was that sex steroid would play an important and sex-specific role in regulating 
chondrocytes as a main regulator of longitudinal bone growth. 
            In chapter 2, the hypothesis of sex-specific role of E2 in chondrocytes was tested 
by investigating the effect of the active metabolite of estrogen 17β-estradiol (E2) on in 
vitro cultured rat costochondral resting zone chondrocytes (RC). E2 has previously been 
shown to regulate rat growth plate chondrocytes through traditional nuclear receptor 
mechanisms, but only female cells exhibit membrane-associated effects mediated through 
protein kinase C (PKC) α. Rat resting zone chondrocytes RCs were isolated from 
costochondral junction of 150 gram female and male Sprague-Dawley rats. Fourth 
passage male and female culture were treated with E2 for 9, 15, 90 minutes and PKC 
activity was measured. E2 caused a rapid membrane mediated increase in PKC activity in 
the female cells within 9 minutes that was maximal at 90 minutes. These results provide 
definitive evidence that RCs exhibit an intrinsic sex-specific response to E2 and suggest 
that sexual dimorphism may be an important variable for cartilage development.  
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              The next aim was to examine the involved of membrane receptor in E2 mediated 
PKC activity in male and female chondrocytes. Fourth passage male and female culture 
were treated with the E2 or its enantiomer Ent-E2 for 9, 15, 90 minutes and PKC activity 
was measured. Only E2, but not ent-E2, caused an increase in PKC specific activity in 
female RCs, indicating that PKC specific activity is stereospecific and regulated by a 
specific membrane-mediated mechanism, while supporting the hypothesis that a specific 
receptor is involved. The involved of caveolae was also tested by treating the confluent 
female resting zone chondrocytes with E2 ± methyl-β-cyclodextrin (β-CD) (cholesterol 
removal). The ability of β-CD to abolish the E2-mediated PKC activity confirmed the 
involvement of the membrane-mediated mechanism via caveolae fraction. 
The next aim was to determine which ERs were involved in this pathway; we 
used the same strategy, by treating the female and male cultures with ERα-selective 
agonist PPT or ERβ-selective agonist DPN. The cultures were treated for 9, 15, and 90 
minutes with PPT or DPN. In addition, female cells were incubated for 90 minutes with 
10
-7
 M E2 in the present or absent of non-specific antibody to IgG, IgM or with specific 
antibodies, for ERα and ERβ respectively. The contribution of ERβ to any change in PKC 





selective antagonist/ERα-agonist (R, R-THC) or 10
-7
 M E2 as positive control for 90 
minutes. Alternatively, female RCs were incubated for 90 minutes with 10
-7
 M E2 in the 




 M (R, R-THC). both ERβ and ERα selective agonists 
DPN and PPT activate PKC at all time points, while the selective ERβ antagonist/ERα-
agonist R, R-THC had no effect suggests that E2 activates PKC by interacting with both 
receptor subtypes in female RCs chondrocytes. Our hypothesis was confirmed by the 
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ability of (R, R-THC) to completely abolish the effect of E2-dependent stimulation of 
PKC. These result indicated that E2-mediated PKC activity via both ERα and ERβ. 
           In chapter 3, after establishing the involvement of membrane receptor, we then 
wanted to test the hypothesis if the sex-specific membrane responses of rat costochondral 
chondrocytes to E2 are due to the difference in the amount or subcellular location of ERα 
and ERβ. Western blots and flow cytometry were used to analyze the expression level 
and the subcellular location of ERα and ERβ in both male and female RC cells. Cell 
fractions of both male and female cells were used to determine the distribution of these 
two receptors subtypes ± treatment of E2. Western blots analysis of cell lysates 
demonstrated the presence of different splicing variants of ERα in both male and female. 
Western blots of cell lysates demonstrated that both male and female chondrocytes 
possess ERα. Western blots of the plasma membrane, Caveolae and nuclear fractions of 
these cells indicated that full length ERα (68KD) as well as truncated isoform ERα 
(46KD) were present in both cells, While based on the intensity of ERα bands its greatest 
concentration in female cells. Truncated isoform ERα (36KD) was also present in plasma 
membrane of female chondrocytes, caveolae and nuclear fraction. However, different 
from male cells, truncated isoform ERα (36KD) was present only in the nuclear fraction.  
          The difference of the amount and distribution of ERα confirmed with our flow 
cytometry result. The number of the plasma membrane ERα in non-permeabilization cells 
as well as total number of ERα in permeabilization cells indicated that female cells have 
more ERα compare to the male. Interestingly, flow cytometry data had showed that 
female chondrocytes had 2 to 3 fold greater number of ERα on the plasma membrane 
compared to male chondrocytes. 
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           Blots of 50 µg protein of male and female cell lysates with ERβ monoclonal 
antibody, demonstrated that both male and female chondrocytes express ERβ. Western 
blots of the whole cell lysates, plasma membrane, caveolae and nuclear fractions of these 
cells indicated that full length ERβ was present in both cells. However, based on the 
intensity of ERβ bands, the concentration of the ERβ in caveolae fraction of female cells 
is present in higher abundant compare to male cells. Taken together, these result 
indicated that female chondrocytes expressed more ERα and ERβ on the membrane than 
male chondrocytes. The different expression level of ERα and ERβ between male and 
female chondrocytes might contribute to their sex-specific membrane responses to E2.    
              To further test the hypothesis that there might be heterodimers complex between 
both receptors, female cultures were treated for 90 minutes with 10
-7
 M PPT in the 
present or absent of 1:500 dilution of nonspecific antibody IgM or specific antibodies for 
ERβ. Alternatively, confluent female cultures were treated for 90 minutes with 10
-7
 M 
DPN in the present or absent of 1:500 dilution of nonspecific antibody IgG or specific 
antibodies for ERα. ERβ antibody completely blocked the effect of ERα activator (PPT) 
to activate PKC. Additionally, ERα antibody completely blocked the effect of ERβ 
activator (DPN) to activate PKC. A heterodimeric complex forming between the two 
receptor subtypes with the treatment of E2 is confirmed by co-immunoprecipitation result, 
which indicates the complex formation in female cultures only with the E2 treatment in 
contrast to the control. These results support our hypothesis that there might be a 
heterodimeric complex forming between two receptors with the treatment of E2.  
          To elucidate the pathway, PKC activity was measured in female chondrocytes that 
were treated with E2 ± U73122 (inhibitor of phospholipase C [PLC]), and PGE2 level was 
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measured in female chondrocytes that were treated with E2± AACOCF3 (inhibitor of 
cytosolic phospholipase A2 [cPLA2]). To examine the similarity in the downstream 
signaling pathway involved in PKC activation between male and female RC cells, male 
and female cells were treated with m-3M3FβS (phospholipase C activator) or  PLAA 
peptide (phospholipase A2 activator) or respectively, and then PKC activity and PGE2 
level were measured respectively.  Although activation of PKC by E2 was observed only 
in female cells, downstream activators m-3M3FβS induced an increase in PKC activity in 
both male and female cells, similarly, PLAA downstream PLA2 activators, PLAA peptide 
induced increase in PGE2 level in both male and female cells. Our study showed that 
female chondrocytes expressed more ERα and ERβ on the membrane and caveolae 
fraction than male chondrocytes while they shared similar signaling pathways. 
            In chapter 4 and 5 of this study, we hypothesized that the active metabolite of 
testosterone Dihydrotestosterone (DHT) can induce sex-specific membrane effects 
similar to other steroid hormones. Confluent cultures of chondrocytes isolated from 





M testosterone or DHT for 3, 9, 90 and 270 min and protein kinase C (PKC) and 
phospholipase A2 (PLA2) activities were measured. DHT induced a dose-dependent 
increase in PKC and PLA2 activity in male cells with the highest increase at 10
-7
 M DHT, 
whereas testosterone had no effect. PKC activity was augmented at 9 and 90 min, and 
then decreased to baseline at 270 min. Neither testosterone nor DHT affected PKC in 
female cells.  
            To examine the potential signaling pathway involved in PKC activation, male 
chondrocytes were treated with 10
-7
M DHT for 9 min in the presence or absence of the 
 xvii 
phospholipase C (PLC) inhibitor U73122, the secretory PLA2 inhibitor quinacrine or the 
cytosolic PLA2 inhibitor AACOCF3; the Gαi inhibitor pertussis toxin (PTX) or the Gαs 
activator cholera toxin (CTX), and the or the general G-protein inhibitor (GDPβS); an 
inhibitor of a Ca-ATPase pump in the endoplasmic reticulum (thapsigargin) and 
inhibitors of specific L type Ca
2+
 channels on the cell membrane (verapamil and 
nifedipine); and an inhibitor of the classical androgen receptor (AR) (cyproterone 
acetate); as well as the transcription inhibitor actinomycin D, or the translation inhibitor 
cycloheximide. U73122, quinacrine, and AACOCF3 inhibited DHT-induced activation of 
PKC.  Inhibition of PLC, G protein, and PLA2 reduced the response of to DHT in a dose 
dependent manner, indicating that PLC, G protein and PLA2 is involved.  
          After establishing the involved pathway, we tested the effect of DHT on the 
differention and proliferation of male chondrocytes. Treatment of male chondrocytes for 
9 minutes with DHT had no effect in [
3
H]-thymidine incorporation in quiescent confluent 
cultures but caused a dose dependent increase in alkaline phosphatase specific activity. 
           In summary, our study showed that the active metabolites of sex steroid hormone 
have a sex specific membrane-mediated affect on chondrocytes. The different expression 
level of ERα and ERβ between male and female chondrocytes or the ability of complex 
formation between these two subtypes might contribute to their sex-specific membrane 
responses to 17β-estradiol. In addition these findings indicate the importance of the 
membrane effects as mediators of DHT action in chondrocytes and suggest the existence 
of a specific membrane receptor for DHT in chondrocytes. The information gleaned from 
this study will provide new information about the role of sex steroid hormones in 
chondrogenesis and has implications in the development of new therapies for the 
 xviii 
treatment of bone fracture healing, and growth plate disorders. The central hypothesis 
was that sex steroid would play an important and sex-specific role in regulating 























BACKGROUND AND LITERATURE REVIEW 
 
            Cartilage is a connective tissue of predominantly mesodermal origin that provides 
mechanical support and structural form to many areas of the musculoskeletal system. 
Cartilage differs from most other tissues due to the fact it does not contain vascular, 
nervous or lymphatic structures. It is composed of a single cell type referred to as the 
chondrocyte and a complex extracellular matrix consisting mostly of collagen and 
proteoglycans. 
            Estrogen is an important regulator of cartilage biology. Both male and female 
growth-plate chondrocytes possess ERα and ERβ [1, 2], E2-BSA, which is not hydrolyzed 
and does not cross the plasma membrane causes many of the same responses as E2 [3], 
suggesting that effects of the hormone previously described as traditional nuclear 
receptor mechanisms may actually result from membrane receptor activation. The effects 
of E2-BSA on PKC activity in rat growth-plate chondrocytes are seen only in female cells 
[4], suggesting that it is the membrane-associated pathway that determines the sex-
specificity of the biological responses to the hormone. This effect is independent of new 
gene expression and occurs via a pathway that involves G-protein-dependent 
phosphatidylinositol-specific phospholipase C (PI-PLC) [5]. Similarly, gender-specific 
activation of PKC has been reported in female human colon cancer cells [6]. PKC 
appears to be involved in the biological effects of E2 as well. In growth plate cells, 
inhibition of PKC with chelerythrine blocks the effects of E2 on proteoglycan sulfation 
and differentiation, but has no affect on E2-dependent proliferation of these cells. In 
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contrast, PKC inhibitors block the action of E2 on DNA synthesis in a number of cell 
types [7, 8]. Studies using E2-bovine serum albumin (BSA) conjugates indicate that it 
may not be necessary for E2 to enter the cell to initiate membrane-associated mechanisms 
[3, 9], suggesting that a membrane receptor may be involved. Moreover the increase in 
PKC in response to E2 or E2-BSA occurs only in cells from female rats, whereas nuclear 
receptors are present in male and female cells and neither the ER agonist 
diethylstilbesterol (DES) nor the ER antagonist ICI 182780 affected E2- or E2-BSA-
stimulated activity [5].These studies demonstrate the critical role of estrogen receptors in 
the sex-specific, membrane-mediated effects of E2 in growth plate chondrocytes. 
 Two natural potent androgens, testosterone and its metabolite dihydrotestosterone 
(DHT), are found in humans and mammals [10]. Both androgens interact with the AR to 
regulate androgen-target gene expression. DHT, which is converted from testosterone by 
5α-reductase isozymes, is the major intracellular androgen and the major mediator of 
androgen actions in the prostate [11]. Like other steroid hormones, testosterone and DHT 
bind to intracellular ARs, inducing receptor dimerization. This facilitates the ability of 
ARs to bind to DNA and recruit coregulators to promote or suppress the expression of 
target genes [12, 13]. This mechanism of steroid action is known as the classical or 
genomic pathway and because it involves gene transcription and mRNA translation, its 
effects may take several hours to days to be seen [14].  
In addition to their genomic actions, it is now understood that steroid hormones 
can also exert actions that are insensitive to inhibitors of transcription and translation and 
occur within seconds to minutes after administration of the hormone [15, 16]. This 
mechanism of steroid action is referred to as non-genomic or non-classical and may result 
 3 
in changes in downstream gene expression via membrane-associated signaling pathways 
[17, 18]. Several studies show that these rapid effects of androgens are mediated by 
cellular signaling pathways involving surface membrane receptors and second 
messengers [19, 20]. In cultured cardiac myocytes, testosterone has been found to induce 
a rapid increase in intracellular Ca
2+
 through activation of a plasma membrane AR 
associated with the pertussis toxin (PTX)-sensitive G protein-coupled phospholipase C 
(PLC), inositol trisphosphate (IP3) signaling pathway [21, 22]. Similarly DHT induces 
protein kinase C (PKC) activity via a PLC dependent pathway [23].  
Sex steroids can elicit sex-specific effects in their target cells via membrane 
associated mechanisms. The ability of testosterone or testosterone coupled to bovine 
serum albumin (T-BSA), which cannot cross the membrane, to increase Ca
2+
 in primary 
osteoblasts is found only in cells from male rats but not from female rats [24]. 
Importantly, the rapid effect of androgens on PKC in costochondral cartilage cells is 
specific to DHT and is found only in chondrocytes from male animals. Testosterone does 
not induce this response in cells from rats of either sex. Estrogens also regulate cells by 
rapid membrane associated signaling pathways in addition to classical ER-dependent 
mechanisms [25] and some of the membrane-associated effects are sex-specific [24]. 
However the exact interaction between androgens and cartilage which plays an important 
role in skeletal growth remain unclear. It is also uncertain whether these actions have a 
physiological role. Therefore, the primary aims of this study were to investigate: (A) the 
rapid actions of DHT in chondrocytes (B) the cellular signaling pathways mediating these 
actions, and (C) their physiological role in male resting zone chondrocytes. 
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             The model system will be used to investigate the non-genomic actions of sex 
steroid hormones and their physiological role, primary rat resting zone chondrocytes.  In 
long bones endochondral bone formation occurs at the growth plate, a region of 
developing cartilage located between the epiphysis and the metaphysis.  Endochondral 
bone formation is regulated in part sex steroid hormone [26, 27].  Androgens stimulate 
endochondral bone growth and elongation [28] while estrogen is known to suppress 
longitudinal bone growth and accelerate growth plate closure [29]. The increases 
observed in periosteal bone formation rates, thus increased bone width, with increased 
bone elongation would be expected to maintain the proportional shape of the bone. 
Increased bone elongation and periosteal apposition were observed with DHT treatment 
even with the administration of estrogen. The effects of androgens on the periosteal bone 
envelope may have been a consequence of the effects on endochondral growth and 
ossification. The insufficient levels of certain sex steroids predispose to bone loss and to 
osteoporotic fractures. For these reasons, resting zone growth plate chondrocytes will be 
used to study the nongenomic effect of sex steroid hormone and their physiological role.   
           The mechanism of non genomic effect of sex steroid hormones will be examined 
in both male and female primary rat resting zone chondrocytes. This study seeks to 
investigate the underlying cause of the  marked differences in physiological responses of 
male and female rat growth plate chondrocytes  to sex steroid hormones, and determine 
which membrane-associated receptor  are responsible for these  effects noted in these 
cells. Collectively, outcomes of this study will provide insights into the cause for rapid 
membrane sex-specific responses to 17ß-estradiol in rat growth plate chondrocytes, and 
non-genomic actions of male steroid hormones in growth plate chondrocytes, the cellular 
 5 
signaling pathways mediating these actions, and their physiological role. The information 
gleaned from this study will provide new information about the role of sex steroid 
hormones in chondrogenesis and has implications in the development of new therapies 






















THE MEMBRANE ASSOCIATED RESPONSE TO 17Β-ESTRADIOL IN 
FEMALE GROWTH PLATE CHONDROCYTES IS MEDIATED BY BOTH Erα 
AND Erβ AND REQUIRES PALMITOYLATION TO TRANSLOCATE THE 
RECEPTORS TO THE PLASMA MEMBRANE 
 
Introduction 
            Estrogens, the main female steroid hormones, are primarily secreted by the 
ovaries in females and are derived from the testes and extragonadal androgens via 
aromatization of testosterone and androstenedione in males [30-32]. Estrogens regulate 
growth, differentiation and function in various target tissues in the human body.  Specific 
receptors for estrogen have been found in growth plate cartilage [33, 34] and fracture 
callus tissue [35], both of which involve endochondral bone formation.   
 Estrogens regulate chondrocyte proliferation and differentiation, resulting in 
growth plate closure during long bone growth [30, 36]. It was thought that these effects 
were mainly caused by classical nuclear receptors, which act as transcription factors, 
thereby modulating gene expression [37].  However, recent studies show that membrane-
associated signaling pathways are also involved [38-40]  
 Estrogen receptors ERα and ERβ are members of the nuclear receptor superfamily 
and their role as ligand-inducible transcription factors has been well established in the 
literature [41, 42]. In many cells, the receptors coexist either as homodimers or as 
heterodimers [43], but the subcellular distribution of the two receptors does not quite 
overlap. A number of variant transcripts have been described for both ERα and ERβ, 
particularly in cancer cell lines [44]. Several of the variant transcripts of the primary ERα 
and ERβ pre-mRNA retain the same reading frame as the full-length transcript. While 
there is considerable information concerning different ERα splice variants, less is known 
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about splice variants of ERβ [45]. Rat ERα splice variants lacking exon 3 and/or 4 
(defined as Ʃ3, Ʃ4 and Ʃ3,4) are all translated into protein in vivo; additionally, their 
expression levels vary according to the animal’s sex [46]. The location of the ER splice 
variants within the cell and their mechanism of action after hormone binding have been 
intensively debated. Although full-length ERs are located primarily in the nucleus at 
steady state, they can shuttle between the nucleus and cytoplasm [47], involving 
relocation of the hormone-receptor complex [48]. Moreover, the fact that the splice 
variants lack certain functional domains raises questions about their role in mediating 
different E2 effects.  
 In the classical nuclear receptor mechanism, estrogens cross the plasma 
membrane and bind to intracellular ERs in the cytoplasm [49].  This induces receptor 
dimerization, facilitating the translocation of the estrogen/receptor complex to the 
nucleus where it binds to specific DNA sequences called estrogen response elements, and 
recruits coregulators to promote or suppress the expression of target genes [50, 51].  
Recent evidence suggests that estrogen, as well progesterone and androgens, also 
induce membrane-associated effects [40, 52-56]. One mechanism occurs when the steroid 
hormone specifically binds to non-classical transmembrane ERs (i.e., different truncated 
forms of ERs), which have been found in the plasma membrane of estrogen-sensitive 
cells [57, 58]. Ligand binding initiates signaling cascades typical of other cell surface 
receptors, including phospholipid metabolism, Ca
++
 ion transport, protein kinase C (PKC) 
activation and ultimately mitogen activated protein kinase (MAPK) activation [39, 59, 
60]. While these signaling pathways can result in altered membrane fluidity by 
generating lysophospholipids and by retailoring the fatty acid residues [60, 61], steroids 
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can also modify membrane fluidity via non specific mechanisms [62-64].  Hydrophobic 
steroids can intercalate into the phospholipid bilayer, with their planar ring system in the 
hydrophobic core of the plasma membrane bilayer of the target cells [65].  This results in 
the perturbation of lipid-lipid interactions [65] that may alter the function of membrane 
proteins and induce an alternate signaling cascade.  
Studies using rat costochondral chondrocytes as a model for growth plate 
cartilage cell maturation [66], have shown that E2 causes rapid increases in protein kinase 
C (PKC) activity in female cells via mechanisms that are independent of new gene 
expression [67].  PKC activation is not affected by the ER antagonist ICI 182780, but can 
be blocked by antibodies to ERα [5], suggesting that non-traditional mechanisms may be 
involved. Moreover, E2 elicits a rapid increase in PKC when incubated directly with 
isolated plasma membranes and cells treated with bovine serum albumin conjugated E2, 
which cannot enter the cell, also exhibit rapid increases in PKC [68, 69]. This indicates 
that specific receptor(s) are involved and that they are present in the plasma membrane.  
Although different structural and functional properties have been reported for the 
plasma membrane–associated ERs by comparison with the nuclear ERα and ERβ [70, 
71], immunocytochemical studies have revealed the presence of a significant fraction of 
nuclear ER also in the plasma membrane [72, 73].  The growth plate chondrocytes 
possess both ER and ER [74, 75] and recent studies show that ER is present in the 
plasma membrane in three molecular forms: the traditional 66kDa nuclear form (ER66), 
a 46kDa form (ER46) and a 36kDa form (ER36) [45]. It is not well understood how 
ERs are maintained or translocated to the plasma membrane. ERs do not possess an 
intrinsic transmembrane domain [76], suggesting that they interact with specific 
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membrane protein(s) [77, 78]. Caveolin-1 has been implicated as has palmitoylation as a 
mechanism for locating ERs at the plasma membrane [79-81]. 
The goal of this study was to determine the specific roles of ER and ER in the 
rapid membrane-associated E2-dependent increase in PKC.  To do this, we used the 
growth plate chondrocyte model described above. The direct receptor binding and 
indirect membrane perturbation effects of the steroid on receptor function can potentially 
be distinguished by observing the differences in the effect of each E2 enantiomer on cell 
response [82].  Accordingly, we determined whether the membrane response was 
mediated by specific receptor/ligand interactions by comparing the effect of E2 and its 
enantiomer ent-E2.  We used selective agonists and antagonists of ER and ER, as well 
as specific blocking antibodies to determine if one or both receptors mediate the 
response.  Finally, we determined if palmitoylation or myristylation of the receptor(s) is 
involved in targeting the receptor(s) to the plasma membrane.   
Materials and Methods 
Reagents 
 17β-estradiol was purchased from Sigma Chemical Co. (St. Louis, MO). ent-17β-
estradiol was prepared as described earlier [83]. ERα monoclonal antibody (ab16460), 
ERβ monoclonal antibody (ab16813), non-specific IgG (ab91353), and non-specific IgM 
(ab91545) were purchased from Abcam (San Francisco, CA). ERα-selective agonist 
propyl pyrazole triol (PPT), ERβ-selective agonist diarylpropionitrile (DPN), and ERβ-
selective antagonist/ERα-agonist (R,R-tetrahydrochrysene [R,R-THC]) [84-86] were 
obtained from Tocris Cookson Inc. (Ellisville, MO, USA). Tunicamycin, an inhibitor of 
palmitoylacetyltransferase, [38] was purchased from EMD Chemicals, Inc. (San Diego, 
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CA, USA). 2-Hydroxymyristic acid (HMA), a myristate antagonist [38], was obtained 
from Cayman Chemical (Ann Arbor, MI). A PKC BioTrak assay kit was obtained from 
GE Lifesciences (Piscataway, NJ) and Dulbecco’s modified Eagle medium (DMEM) was 
obtained from GIBCO-BRL (Gaithersburg, MD). A PLA2 assay kit was obtained from 
Cayman Chemical (Ann Arbor, MI). The protein content of each sample was determined 
using the bicinchoninic acid (BCA) protein assay kit [87] obtained from Pierce Chemical 
Co. (Rockford, IL). [
32
P]-ATP was obtained from Perkin Elmer (Melville, NY).  
Chondrocyte Cultures 
 The culture system used in this study has been described in detail previously [88]. 
Chondrocytes were isolated from the resting zone of the costochondral junction of 150 
gram female Sprague-Dawley rats. To eliminate the contamination by fibroblasts and 
osteoblasts, perichondrial tissue and calcified cartilage were discarded. After dissection, 
the cartilage was thinly sliced and cells were released from the tissue by sequential 
incubations in 0.25% trypsin-EDTA for 1 hour after which the initial digest was 
discarded to further eliminate contaminating cells. Pure chondrocyte isolates were then 
obtained by digestion in 0.02% Type II collagenase for 3 hours in Hank’s balanced salt 
solution. Chondrocytes were plated at an initial density of 10,000 cells/cm
2
 and 
maintained in DMEM containing 10% fetal bovine serum (FBS) and 50 μg/ml ascorbic 
acid in an incubator at 5% CO2 and 100% humidity at 37
o
C. The culture medium was 
replaced after 24 hours and then every 48 hours until cultures reached confluence. Fourth 
passage cells were used for all experiments based on previous studies showing that these 
cells preserve their chondrogenic phenotype as well as their differential responsiveness to 
vitamin D metabolites at this passage [89]. 
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ERα/ERβ Complexes 
 In order to determine if ER and ER form a complex, confluent chondrocyte 
cultures were incubated for 90 minutes with 10
−7
 M E2, and a monoclonal antibody to 
ER were used to immunoprecipitate the receptor and associated proteins from cell 
lysates.  At harvest the cell layers were washed with PBS and the cells were lysed and 
sonicated in RIPA buffer (50 mM Tris–HCl, 150 mM NaCl, 5 mM disodium EDTA, 1% 
Nonidet P-40) containing 100 mM NaF, protease inhibitor cocktail (Sigma–Aldrich) and 
1 mM phenylmethylsulfonyl fluoride (PMSF). Protein samples were mixed with either 
anti-ERα antibody and incubated at 4°C overnight with continuous agitation. 
Immunoprecipitation was measured in protein samples using a commercially available 
Dynabeads® Protein kit following the manufacturer’s directions (Invitrogen, Grand 
Island, NY).The immunoprecipitated samples were then subjected to Western blot 
analysis. Whole cell lysates and the immunoprecipitated proteins were separated on a 4-
20% gradient acrylamide gel. Western blots of the gels were probed with either the 
mouse monoclonal antibody to ERα (ab16460) or anti-ERβ monoclonal antibody 
(ab16813). In order to lower the background in the images, a ONE-HOUR IP-Western 
Kit (Genscript) was used.  Immunoreactive bands were visualized using goat anti-mouse 
horseradish peroxidase-conjugated secondary antibodies (Bio-Rad, Hercules, CA). The 
Super Signal West Pico Chemiluminescent System (Thermo Fisher Scientific) was used 
to treat the membrane and then imaged with the VersaDoc imaging system (Bio-Rad). 
Regulation of Protein Kinase C Activity 
 Initial experiments determined the time course of E2 and ent-E2 regulation of PKC 
activity. Confluent fourth passage female cells in 24 well plates were treated for 9, 15 and 
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90 min with 0.5 ml of ethanol at highest concentration used in experimental cultures or 
experimental media (DMEM + 10% FBS + various concentrations E2 or ent-E2). Dose 




 M E2 or 
ent-E2. In order to determine which ERs were involved in this pathway, we used the same 
strategy, by treating the female cultures with ERα-selective agonist PPT or ERβ-selective 
agonist DPN. The cultures were treated for 9, 15, and 90 minutes with PPT or DPN. 





 M PPT or DPN.  
The contribution of ERβ to any change in PKC activity was determined by 




 M selective antagonist/ERα-
agonist (R,R-THC) or 10
-7
 M E2 as positive control for 90 minutes. Alternatively, female 
RCs were incubated for 90 minutes with 10
-7





 M (R,R-THC).  
In addition, female cells were incubated for 90 minutes with 10
-7
 M E2 in the 
presence or absence of non-specific antibodies IgG and IgM or with specific monoclonal 
antibodies to ERα and ERβ, respectively. Antibodies were added to the cultures at a 
1:500 dilution. Although these antibodies are specific for the intracellular ERs, the anti-
ERα antibody has been used successfully to label protein in the plasma membrane [90]. 
 To further evaluate if both ERα and ERβ are involved, and to test the hypothesis 
that there might be a heterodimers complex between them, female cultures were treated 
for 90 minutes with 10
-7
 M PPT in the presence or absence of a 1:500 dilution of IgM or 




 M DPN in the presence or absence of 1:500 dilution of IgG or the anti-
ERα antibody. 
 To assess the role of palmitoylation or myristylation of ERs in regulating PKC 
activity, female cells were pre-incubated for 2 hours with 30μM tunicamycin [57] or with 
0.5mM 2-hydroxymyristic acid (HMA) [57], and then with 10
-7
 M E2 for 90 minutes. In 
addition, to determine the specific role of palmitoylation of either ERα or ERβ, female 
chondrocyte cultures were treated for 2 hours with 30μM tunicamycin and then with 
either 10
-7
 M PPT or 10
-7
 M DPN for 90 minutes. 
 After the incubation period, cell layers were washed with PBS to remove any 
excess medium and then lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 
5 mM EDTA, 1 mM phenylmethylsulfonylflouride, and 1% NP-40). 25μl of the cell 
lysates were assayed for protein content [87]. PKC activity was measured in cell lysates 
using a kit following the manufacturer’s directions (Amersham Bioscience). This kit is 
optimized for measurement of phospholipid and Ca
2+
-dependent PKC [91, 92]. 
Regulation of Phospholipase A2 Activity 
 To determine if either or both receptors mediate the effects of E2 on PLA2 
activity, the following protocol was used.  For each experiment, confluent cultures of 
female chondrocytes in 24 well plates were treated for 90 minutes with 0.5 ml of the 
control medium (0.02% ethanol in DMEM + 10% FBS) or experimental medium 
(DMEM + 10% FBS + various concentrations of E2). After the treatment period, cell 
layers were washed with PBS and then cells were sonicated in 0.1 ml of cold buffer (50 
mM 4-2 hydroxyethyl-1-piperazineethane sulfonic acid containing 1 mM EDTA). Cell 
pellets were obtained by centrifugation for 15 minutes. 25μl of the cell lysates were 
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assayed for protein content. PLA2 activity was measured in cell supernatant using a kit 
following the manufacturer’s directions (Cayman Chemical). Samples were analyzed 
using a plate reader at 414 nm [61, 93, 94]. 
 To better understand the role of ERs in regulating PLA2 activity, confluent female 
cultures were treated for 90 minutes with 10
−7
 M E2 in the presence or absence of the 
anti-ERα antibody or nonspecific mouse IgG. Alternatively, female cultures were treated 
for 90 minutes with 10
−7
 M E2 in the presence or absence of anti-ERβ antibody. 
Statistical Management of the Data 
 For each experiment, each value represents the mean ± SEM of the cell layers of 
six independent cultures. Statistical significance was determined by ANOVA; P<0.05 
was considered significant. Each experiment was repeated two or more times to ensure 
the validity of the results. The data presented are from a single representative experiment. 
Results 
 Female resting zone chondrocytes possess ER and ER (Figure. 2.1).  Western 
blots of whole cell lysates demonstrate the presence of ER68, ER46, and ER36 as 
well as ER59.  Immunoprecipitates of the lysates using antibodies to ER confirm that 
ER68, ER46, and ER36 are present in control cultures, but the amount of ER59 is 
considerably reduced in comparison to the whole cell lysates.  Treatment of the cells with 
E2 for 90 minutes increased the amount of ER68, ER46 and ER59 in the anti-ER 
antibody immunoprecipitates, suggesting that they have formed a complex. 
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Figure 2.1: ERα was immunoprecipitated and subjected to Western blot. The 
membranes were incubated with the anti-ERα and anti-ERβ antibodies. C: control group, 
T: E2 treated group. 
 
 
             The effect of E2 on PKC is receptor-mediated.  Only E2, but not ent-E2, caused an 
increase in PKC specific activity in female RCs (Figure 2.2A, B). A 2-fold increase in 
PKC activity was evident at 9 minutes, a 2.4-fold increase at 15 minutes and a 3.5-fold 
increase at 90 minutes in response to E2. The effects of E2 were dose-dependent with the 
greatest increase in PKC activity observed in cells treated with 10
-7
M E2 (Figure 2.2C). 
Antibodies to ERβ or ERα blocked the E2-stimulated PKC activity completely whereas 
non-specific IgM and IgG had no effect (Figure 2.2D, E), suggesting that both receptors 
were involved.  
Time 
Treatment  
 90         90           90 
 C           T             C 
WCL IP: ERα 
 










Figure 2.2: Time course and dose-dependent effect of E2, ent-E2 and role of ERs in 
PKC specific activity in female resting zone chondrocytes. Time course was 
determined by treating chondrocytes for 9, 15, and 90 minutes with 10
-7
 M E2 (A) or 10
-7
 





 M E2 or ent-E2 (C). Role of ERs was tested by treating the cells 
for 90 minutes with 10
-7
 M E2 ± anti-ERα antibody (D) or E2 ± anti-ERβ antibody (E). 
PKC specific activity was measured in cell layer lysates. Values are the mean ± SEM for 
six independent cultures for each variable. *P<0.05, treatment vs. control at each time 
point. 
 
 Both the ERα-selective agonist PPT and the ERβ-selective agonist DPN activated 
PKC at all time points examined (Figure 2.3A,B) and both agonists exhibited comparable 
dose-response effects at 90 minutes (Figure 2.3C).  PKC activity was not significantly 




 M (R,R-THC), which is an agonist for ER 
and an antagonist for ER (Figure 2.3D). However, R,R-THC blocked the stimulatory 
effect of E2 (Figure 2.3E).  
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Figure 2.3: Time course and dose-dependent effect of ERα and ERβ agonists on PKC 
specific activity in female resting zone chondrocytes. The time course was determined by 
treating the chondrocytes for 9, 15, and 90 minutes with 10
-7
 M PPT (A) or 10
-7
 M DPN 










 M R,R-THC or 10
-7
 M E2 as a positive control (D) or with 
10
-7




 M R,R-THC (E). PKC activity was measured in cell layer lysates. 
Values are the mean ± SEM for six independent cultures for each variable. *P<0.05, 
treatment vs. control 
 
             Treatment of the chondrocytes with antibodies to ERβ completely blocked the 
stimulatory effect of the ERα agonist PPT on PKC; and antibodies to ERα blocked the 
effect of the ERβ agonist DPN (Figure 2.4A,B). Tunicamycin (30µM) was able to 
completely abolish the effect of E2 on PKC activity whereas HMA had no effect (Figure 
2.4C,D), indicating that palmitoylation but not myristylation was required. Additionally, 
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tunicamycin blocked the stimulatory effect of PPT and DPN on PKC specific activity 
(Figure 2.4E).  
 
Figure 2.4: Involvement and palmitoylation of ERα and ERβ are required in E2-
mediated PKC activity. Female cultures were treated for 90 min with 10
-7
M PPT ± anti-
ERβ antibody (A), or for 90 minutes with 10
-7
M DPN ± anti-ERα antibody (B). Effect of 
palmitoylation of ERs on E2-dependent PKC activity:  Female cultures were pre-
incubated for 2 hours with 30µM tunicamycin (C), or 0.5mM 2-hydroxymyristic acid 
(D). Then cells were treated for 90 minutes with 10
-7
 M E2. The same strategy was used 
by pre-incubating the cells for with 30µM tunicamycin (E); then cells treated for 90 
minutes with 10
-7
M PPT or DPN. PKC specific activity was measured in cell layer 
lysates. Values are the mean±SEM for six independent cultures for each variable. 
*P<0.05, treatment vs. control, ^P<0.05, E2+tunicamycin vs. E2 alone or PPT + 






 E2 dependent signaling via PLA2 was also regulated by the two receptors.  
Chondrocytes treated with E2 exhibited increased PLA2 specific activity (Figure 2.5A) 
and a 1: 500 dilution of antibodies to either ERβ or ERα completely blocked this effect 
whereas IgM and IgG had no effect (Figure 2.5B,C).  
 
 
Figure 2.5: Involvement of ERα and ERβ in E2-mediated PLA2 activity. Confluent 




 M E2 (A), 
or with 10
-7
 M E2 ± anti-ERα antibody (B), or with 10
-7
 M E2 ± anti-ERβ antibody (C). 
PLA2 specific activity was measured in cell layer lysates. Values are the mean ± SEM for 







M E2. Involvement of ERα and ERβ in E2-mediated PKC activity: Female 
cultures were treated for 90 min with 10
-7




M DPN ± anti-ERα antibody (E). PKC specific activity was measured 
in cell layer lysates. Values are the mean ± SEM for six independent cultures for each 
variable. *P<0.05, treatment vs. control of each experiment.  
 
Discussion 
 The ability of E2 to signal from plasma membrane receptors impacts both the 
genomic and nongenomic actions of the sex steroid. Estrogen activation of MAPK via src 
has been shown to occur in male and female osteoblasts [95]. MAPK can also be 
activated via PKC [96] and studies in our lab [97, 98] and others [99] suggested that the 
PKC signaling pathway and downstream MAPK activation [100, 101] in response to E2 
may be active only in cells from female animals or human donors. However, the actual 
receptors that mediate these responses to E2 were not determined.  
 Our studies show that female growth plate resting zone chondrocytes respond to 
estrogen with an increase in both PKC and PLA2 activities via ERα and ERβ. That the 
effect of E2 is specific and receptor mediated was demonstrated by the fact that only E2 
but not Ent-E2 had an effect on PKC activation. Because enantiomers are structural 
mirror images with identical physicochemical properties and receptors have well-defined 
and structurally discriminate binding pockets, they can generally identify specific ligands 
of different conformations. In contrast, membrane lipids present a dynamic environment 
that does not maintain structurally well-defined binding sites for steroids [102]. Thus, the 
difference in the effect of each enantiomer (E2 and Ent-E2) on the cell response implies 
that the binding affinity of E2 to the specific receptor is more effective than its 
enantiomer (Ent-E2). This supports our previous work showing that the stimulatory effect 
of E2 on PKC signaling is stereospecific [61, 67].  
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 Our results demonstrate that both ER and ER are involved in mediating the 
rapid membrane-associated effects of E2 on PKC and PLA2 signaling pathways.  
Antibodies specific for ERα and ERβ blocked the stimulatory effects of E2 on both 
enzymes. In addition, specific agonists for ER and ER stimulated PKC with dose-
response and time course comparable to that of E2.  R,R-THC, which is an agonist for 
ER and an antagonist for ER had no effect on PKC, further supporting the requirement 
for both receptors.   
 The observation that E2 treatment resulted in co-immunoprecipitation of 
ER/ER, suggests that a complex is formed.  We did not test whether such a complex is 
required for membrane associated signal transduction to occur, but the fact that antibody-
blocking of selective agonists for each receptor blocked the effect of E2 is strong 
presumptive evidence that this is the case.  These results support previous studies showed 
that ER dimerization promotes selective G-protein activation and the loss of the dimer 
fails to provide the structural contact points for G-proteins to bind in an active 
conformation, thus impairing signaling to adenylate cyclase [103]. ERs have also been 
shown to form a complex with androgen receptor in response to treatment with E2 or 
dihydrotestosterone [104].   
 ERα [105] and ERβ [106], as well as truncated forms of both receptors are present 
in the plasma membrane [107, 108] and caveolae [109, 110], implying that membrane 
forms of these receptors may play a role in mediating rapid responses to the hormone. We 
did not address this hypothesis directly in the present study since the 
immunoprecipitation studies were performed using cell lysates and not isolated plasma 
membranes.  However, our results do show that palmitoylation is required for rapid 
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activation of PKC by E2, indicating that receptor recruitment to the membrane is involved 
[111, 112]. In contrast, inhibition of myristylation had no effect on E2-dependent PKC 
activation, indicating that the ERs responsible for mediating the hormone’s effect were 
not integral to the plasma membrane via this mechanism [113].   
            ERs do not display an intrinsic transmembrane domain [76]; thus an interaction of 
ERs with specific membrane protein has been proposed to explain their membrane 
localization [77, 78]. The interaction between ERs caveolin-1 and palmitoylation of ERs 
are the major determinants for the residence of ERs at the plasma membrane [79-81]. In 
this study, we found that posttranslational palmitoylation is required for ER membrane 
localization and for E2-induced recruitment of ERs to the plasma membrane. It is possible 
that by palmitoylation, ERs are dynamically recruited from the cytoplasmic pool to the 
plasma membrane and most likely to the caveolae, which contains other signaling 
molecules including G protein α-subunits, kinases, and caveolins [114]. The interaction 
between palmitoylated ERs and other caveolae proteins may act as a signal for the 
directional recruitment and restructuring of the receptor. Consequently, ERs were able to 
mediate further stimulation of PKC activity at 90 minutes. Thus, palmitoylation seems to 
be a common regulatory mechanism in the formation of membrane-associated signaling 









SEX SPECIFIC RESPONSE OF GROWTH PLATE CHONDROCYTES 
TO 17β-ESTRADIOL DIFFERENCIAL REGULATION OF PLASMA 
MEMBRANE ASSOCIATED ESTROGEN RESCEPTOR 
 
Introduction 
Longitudinal growth is regulated by the activity of chondrocytes in the epiphyseal 
growth plates of long bones. Many hormones and growth factors are involved in the 
regulation of this process. Among these, sex steroids are of crucial importance, especially 
during puberty [116]. Estrogens are involved in the initiation of the pubertal growth spurt 
and in fusion of the growth plate at the end of puberty in both boys and girls. Levels of 
systemic estrogens are important variables, but the number and type of estrogen receptors 
(ERs) are also critical determinants growth plate response to the hormone [117, 118].  
Both ERα and ERβ are present in growth plates of both males and females at the 
mRNA and protein level in several species, including rat, rabbit, and human [119-122], 
indicating that estrogens can directly regulate the tissue in addition to their indirect 
effects via growth hormone [123-127].  Moreover, experiments using fetal rat and 
neonatal mouse bone organ cultures show that they regulate growth plate development in 
a sex-specific manner [128]. Because the organ cultures were independent of systemic 
sex steroids, the results suggested that the sexual dimorphism was at the cellular level. 
Although the binding affinity of E2 for ERs in growth plate chondrocytes was comparable 
in cells from both male and female rats, female cells had greater numbers of receptors 
than male cells [129].   
While this could contribute to differences in response rate, it did not explain the 
marked differences in biological responses observed between male and female cells. 
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Whereas E2 caused an increase in chondrocyte differentiation in female cells, it did not 
do so in male cells [130].  This effect of E2 was stereospecific, indicating that it was 
receptor mediated.  However, the mechanism involved differed from that mediating the 
effect of E2 on chondrocyte apoptosis, which was the same in cells from both sexes [38].  
Subsequent studies identified plasma membrane associated signaling in the sex-specific 
responses.  E2 caused rapid increases in Ca
++
 ion transport [60] and activation of protein 
kinase C (PKC) [98] and phospholipase A2 [61] in female chondrocytes but not in male 
cells. Importantly, these effects of E2 could also be seen in cells treated with E2-
conjugated to bovine serum albumin (E2-BSA), which can’t pass the plasma membrane, 
was also able to stimulate PKC. Moreover, inhibition of PKC signaling blocked the 
downstream effect of E2 on chondrocyte differentiation [59]. The fact that neither 
diethylstilbesterol nor ICI 182780, which are known to act via the nuclear ER, had an 
effect on the membrane associated response [59]. 
We hypothesized that ERs resident in the plasma membranes of growth plate 
chondrocytes might be responsible for the differential responses seen in male and female 
cells.  ERα [131, 132]  and ERβ [133-135] are the products of separate genes. In many 
cells, they coexist either as homodimers or as heterodimers [43, 136]. Recent evidence 
indicates that there are specific actions of E2 that can be attributed to one receptor but not 
the other [137, 138]. This is supported by in vitro studies where estrogen analogs have 
been shown to preferentially activate the two ERs [139]. These observations, coupled 
with the fact that ERβ can form homodimers and heterodimers with ERα in vitro [43, 
136], suggest the activity of estrogens may depend on whether a cell contains ERα, ERβ, 
or both. 
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While it is known that ERα and ERβ are both present in male and female cells, it 
is not known if they are differentially expressed or activated. It is also not known if they 
are transported to the membrane in a comparable manner.  Of particular importance is if 
the membrane associated signaling pathways needed to mediate the downstream 
responses to E2 are present in male growth plate chondrocytes. In this study, we 
compared the expression and subcellular localization of ERα and ERβ in male and female 
rat costochondral growth plate chondrocytes; we determined if their presence in the 
membrane involved palmitoylation as has been shown in other systems; and we 
investigated differences in the potential downstream signaling pathways. 
Material and Methods 
Reagents 
17β-Estradiol (E2); methyl-β-cyclodextrin (β-CD), which depletes lipid rafts and 
alters the caveolar microenvironment [72, 140]; the phospholipase C (PLC) inhibitor 
U73122 [141]; and the PLA2 inhibitor AACOCF3 [142] were purchased from Sigma 
Chemical Co. (St. Louis, MO). The ERα-selective agonist propyl pyrazole triol (PPT) 
[143-145] ; the PLC agonist m3M3FβS [146] ; and the ERβ-selective agonist 
diarylpropionitrile (DPN) [143-145] were obtained from Tocris Cookson Inc. (Ellisville, 
MO). Tunicamycin, an inhibitor of palmitoylacetyltransferase [113], was purchased from 
EMD Chemicals, Inc. (San Diego, CA). ERα monoclonal antibody (ab16460) and ERβ 
monoclonal antibody (ab16813) were purchased from Abcam (San Francisco, CA).  A 
polyclonal antibody to caveolin-1 (Cav-1) was purchased from Santa Cruz Biotechnology 
(sc-894, Santa Cruz, CA).  PKC BioTrak assay kits were obtained from GE Lifesciences 
(Piscataway, NJ) and Dulbecco’s modified Eagle medium (DMEM) was obtained from 
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GIBCO-BRL (Gaithersburg, MD). The protein content of each sample was determined 
using the bicinchoninic acid (BCA) protein assay kit [87] obtained from Pierce Chemical 
Co. (Rockford, IL). [
32
P]-ATP was obtained from Perkin Elmer (Melville, NY). 
Chondrocyte Cultures 
The culture system used in this study has been described in detail previously 
[147]. Chondrocytes were isolated from the resting zone cartilage of the costochondral 
junction of 150 gram male and female Sprague-Dawley rats, plated at an initial density of 
10,000 cells/ cm
2
, and maintained in DMEM containing 10% fetal bovine serum (FBS) 
and 50 μg/ml ascorbic acid. The medium was replaced after 24 hours and then every 48 
hours until cultures reached confluence. Fourth passage cells were used for all 
experiments based on previous studies showing that these cells preserve their 
chondrocyte phenotype as well as their differential responsiveness to vitamin D 
metabolites at this passage [89].  Confluent fourth passage male and female cells in 24 
well plates were treated for 90 minutes with 0.5 ml of ethanol at the highest concentration 
used in experimental cultures or experimental media (DMEM + 10% FBS + appropriate 
concentration of E2). 
ER Expression and Subcellular Localization 
Plasma Membrane and Caveolae Isolation 
Plasma membranes were isolated using a detergent-free method as described 
previously [148]. Confluent, fourth passage resting zone chondrocytes isolated from 
female and male rats were treated with either 10
−7
 M E2 or vehicle for 90 minutes. The 
cell layers were washed two times with 1XPBS to remove any residual medium and cells 
were harvested by scraping using isolation buffer (0.25 M sucrose, 1 mM EDTA, 20 mM 
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Tricine, pH 7.8). Cells were homogenized using a tissue grinder and the homogenate 
centrifuged at 3500rpm for 10 minutes to pellet large debris including the nucleus, 
mitochondria, and endoplasmic reticulum.  The supernatant was collected and layered on 
30% Percoll in isolation buffer (GE Healthcare, Piscataway, NJ). Plasma membranes 
were collected from the samples by centrifuging at 30,500 rpm for 30 min and removing 
the visible band in the middle of the gradient column. The plasma membrane fraction was 
then layered over a 10–20% OptiPrep gradient (Sigma–Aldrich), and the gradient was 
centrifuged at 26,500 rpm for another 4 hours. Plasma membrane sub-fractions were 
collected from the top to the bottom of the tube, which resulted in isolation of 15 
fractions. Caveolae were observed as an opaque band, which was collected in fraction 3. 
Western blots were used to determine if ERα and/or ERβ were present in whole 
cell lysates and the distribution of the ER isoforms in plasma membranes and caveolae in 
the male and female cells. Plasma membranes, the caveolae fraction and the nuclear 
fraction were separated on 4-20% gradient acrylamide gels. Blots of the gels were probed 
with either the mouse monoclonal antibody against ERα or the mouse monoclonal 
antibody against ERβ.  In addition, blots were probed using a polyclonal antibody to 
caveolin-1 (Cav-1). Immunoreactive bands were visualized using goat anti-mouse 
horseradish peroxidase-conjugated secondary antibodies (Bio-Rad, Hercules, CA). The 
Super Signal West Pico Chemiluminescent System (Thermo Fisher Scientific) was used 
to treat the membrane and then imaged with the VersaDoc imaging system (Bio-Rad). 
Palmitoylation  
To assess the role palmitoylation in localizing ERα and ERβ to the plasma 
membrane as well as the role of E2 in regulating ERα and ERβ palmitoylation, male and 
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female cultures were pre-incubated with 30μM tunicamycin for 2 hours. The cells were 
then treated with 10
-7
 M E2 for 90 minutes. Plasma membranes were isolated and 
analyzed as above. 
Receptor Complex Formation 
To determine if the ER isoforms formed complexes in response to E2, fourth 
passage chondrocytes from female rats were treated ±10
−7
 M E2 for 90 min. At harvest 
the cell layers were washed with 1XPBS and the cells were lysed and sonicated in RIPA 
buffer (50 mM Tris–HCl, 150 mM NaCl, 5 mM disodium EDTA, 1% Nonidet P-40) 
containing 100 mM NaF, protease inhibitor cocktail (Sigma–Aldrich) and 1 mM 
phenylmethylsulfonyl fluoride (PMSF). Protein samples were mixed with anti-ERα 
antibody and incubated at 4°C overnight with continuous agitation. Immunoprecipitation 
was measured in protein samples using a commercially available Dynabeads® Protein kit 
following the manufacturer’s directions (Invitrogen, Grand Island, NY). In order to lower 
the background in the images, a ONE-HOUR IP-Western Kit (Genscript) was used.  The 
immunoprecipitated samples were then subjected to Western blot analysis.   
Receptor Number 
The number of the ERs on the plasma membrane and intracellularly were 
evaluated by flow cytometry using the Quantum Simply Cellular Microbeads Kit (Bangs 
Laboratories, Inc. Fishers, IN). This kit provides a method for the evaluation of the 
number of molecules of antibody per cell. Briefly, this kit is comprised of populations of 
uniform cell-sized microspheres with different calibrated binding capacities of goat anti-
mouse IgG (FC-specific) on their surface. The kit includes 4 coated populations, each 
with different antibody binding capacity (ABC) for mouse monoclonal antibodies, and 1 
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blank population with no specific binding capacity for mouse IgG. When the bead 
populations are labeled in the same manner as the cells to be analyzed, they provide a 
means of constructing a QuickCal
®
 calibration curve (ABC values versus fluorescence 
intensity), from which samples may be analyzed.  
The number of ERα cell surface receptors was determined by incubating male and 
female cell suspensions (5*10
5
 cells) for 30 minutes in 150µl 1% BSA with a 1:50 
dilution of the ERα monoclonal antibody.  Cells were then washed with 1 ml 1% BSA, 
centrifuged for 5 minutes at 1000 rpm, and resuspended in 150µl 1% BSA containing a 
1:500 dilution of goat-anti mouse antibody conjugated to Alexa Fluor® (Invitrogen, 
Grand Island, NY) for 30 minutes in the dark. Cells were centrifuged at 1000 rpm for 10 
minutes and resuspended in 300μl PBS. After collecting the cells by filtration, samples 
were ready for analysis.  
To determine the total number of receptors (surface and cytoplasmic), cells were 
fixed by incubating with 4% paraformaldhyde in 1XPBS for 20 minutes at 4
o
C. Then 
cells were collected by centrifugation at 1000 rpm for 10 minutes and resuspended in 
permeabilization solution (0.5% Triton X-100 in PBS) at room temperature for 15 
minutes. Permeabilized cells were incubated with the primary antibody and further 
processed as described above. Microspheres (50μL per tube) were incubated with the 
secondary antibody, washed and further processed on the flow cytometer under the same 






Protein Kinase C Activity 
 Confluent fourth passage male and female cells in 24 well plates were treated for 
90 minutes with 0.5 ml of ethanol at the highest concentration used in experimental 




 M E2). To determine 





 M ERα-selective agonist PPT or ERβ-selective agonist DPN, 
respectively. To determine if the increase in PKC was caveolae dependent, female 
cultures were pre-incubated for 30 minutes with 5mM methyl-β-cyclodextrin (β-
CD)[140], and then treated for 90 minutes with 10
-7
 M E2.  
We previously showed that phosphatidylinositol-specific phospholipase C (PLC) 
mediated the rapid increase in E2-dependent PKC [59].  To establish if PLC also plays a 
role in the increase in PKC at 90 minutes, confluent cultures of female cells were treated 
with E2 ± the PLC inhibitor U73122.  To determine if the downstream signaling pathway 
was functional in male cells, male and female cells were treated with PLC activator m-
3M3FβS and PKC activity was measured.  After the incubation period, cell layers were 
washed with 1XPBS to remove any excess medium and then lysed in solubilization 
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 mM 
phenylmethylsulfonylflouide and 1% NP-40). 25μl of the cell lysates were assayed for 
protein content [87]. PKC activity was measured in cell lysates using a kit following the 
manufacturer’s directions (Amersham Bioscience). This kit is optimized for measurement 
of phospholipid and Ca
2+
-dependent PKC [149, 150]. 
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Regulation of PGE2 Release 
PGE2 production is a downstream consequence of PLA2 activation and can 
activate the protein kinase C (PKC) signaling pathway leading to ERK1/2 activation [39].  
To determine if PGE2 release into the medium is produced in response to E2, female cells 




 M of the PLA2 inhibitor AACOCF3, 
and then cells were treated with 10
-7
 M E2 for 90 minutes. Male and female cells were 




 M PLAA peptide, which activates PLA2 [151]. 
At the end of the incubation, the media were acidified and PGE2 was measured using a 
commercially available kit (Prostaglandin E2 [
125
I]-RIA kit, NEK020001 K, Perkin 
Elmer, Waltham, MA). PGE2 data were normalized to total DNA (Quant-iT™ 
PicoGreen
®
 dsDNA Assay kit, P11496, Invitrogen). 
Statistical Management of the Data 
For each experiment, each value represents the mean ± SEM of the cell layers of 
six independent cultures. Statistical significance was determined by ANOVA. P<0.05 
was considered significant. Each experiment was repeated two or more times to ensure 
the validity of the data. The data represented are from a single representative experiment.    
Results 
 Western blots of the cell lysates demonstrated that ERα was present in female and 
male resting zone chondrocytes (data not shown).  The nuclear fraction from both cell 
types exhibited all three ERα isoforms: ERα68, ERα46 and ERα36 (Figure 3.1A,B).  
Plasma membranes from female chondrocytes had all three isoforms, but male cells 
lacked ERa36.  This was also the case for caveolae.  ERβ59 was present in  plasma 
membranes and nuclear fraction from female and male cells and was present in caveolae 
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from female cells but not male cells (Figure 3.1C,D). Intact caveolae were required E2 
activation of PKC in female cells.  Treatment with methyl β-cylodextrin blocked the 
stimulatory effect of the hormone (Figure 3.1 E) 
 
Figure 3.1:  Difference in the amount and subcellular localization of ERα and ERβ 
between male and female chondrocytes. Subcellular localization of ERα in female 
resting zone chondrocytes (A), or male resting zone chondrocytes (B). Subcellular 
localization of ERβ in female resting zone chondrocytes (C), or male resting zone 
chondrocytes (D). WCL Whole cell lysates, PM plasma membrane, F3 of caveolae 
fraction, and NF nuclear fraction were isolated and subjected to western blot. Female 
cultures were pre-incubated for 30 minutes with 5mM methyl-β-cyclodextrin (β-CD) then 
cells were treated with 10
-7
 M E2 for 90 minutes. PKC specific activity was measured in 
cell layer lysates. Values are the mean± SEM for six independent cultures for each 














Sex-specific differences in the amount and distribution of ERα were confirmed by 
flow cytometry. There was more than twice as much plasma membrane ERα in non-
permeabilized female cells than in male cells. Total ERα in permeabilized cells was not 
statistically different, however (Figure 3.2 A,B). Interestingly, the percentage of positive 
cells was not significantly different in both permeabilized and non-permeabilized cells 
female and male cells. 
 
Figure 3.2: Difference in the number of ERα between male and female 
chondrocytes.  Flow cytometry result showing the number of the plasma membrane ERα 
in non permeabilization cells (A), and the number of total ERα (plasma membrane and 
nuclear receptors) in permeabilization cells (B). Values are the mean ± SEM for six 
independent cultures for each variable. *P<0.05, female vs. male. 
 
Tunicamycin reduced the amount of ERα68 in whole cell lysates of female 
chondrocytes but had no effect on the male cells (Figure 3.3 A,B).  E2 caused an increase 
in plasma membrane ERα46 and ERα36, as well as ERβ59 in female cells, all of which 
were reduced by pretreatment with tunicamycin.   
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Figure 3.3: Palmitoylation of the membrane receptor is required for E2-dependent 
PKC activity only in female chondrocytes. Female cells were either treated for 90 
minutes with 10
-7
 M E2 alone or with 30μM tunicamycin for 2 hours then cells were 
treated with 10
-7
 M E2 for 90 min. Presence of ERα and ERβ in female chondrocytes (A) 
or male chondrocytes (B) in whole cell lysates and plasma membrane was examined by 
western blot. 
 
These observations were confirmed by co-immunoprecipitation of ERα. 
Treatment of female chondrocytes for 90 minutes with E2 increased the amount of 
ERα68, ERα46 and ERβ59 that was present in the immunoprecipitates, but in male cells, 
the levels of all three isoforms were reduced (Figure 3.4).  
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Figure 3.4. ERα was immunoprecipitated and subjected to Western blot. The 
membranes were incubated with anti-ERα and anti-ERβ antibodies. C: control group, T: 
treated group. 
 
            Both ERα and ERβ were involved in the E2-dependent activation of PKC in 
female cells.  Treatment of the cells with the ERα agonist PPT (Figure 3.5A) or the ERβ 
agonist DPN (Figure 3.5B) had the same stimulatory effect on PKC as E2.  In contrast, 






Figure 3.5: Dose-dependent effect of PPT and DPN on PKC specific activity on 
resting zone chondrocytes. Confluent fourth passage female and male chondrocytes 








 M DPN (B).PKC 
specific activity was measured in cell layer lysates. Values are the mean± SEM for six 
independent cultures for each variable. *P<0.05, treatment vs. control at each time point. 
 
Inhibition of PLC blocked the stimulatory effect of E2 on PKC in the female cells, 
even at 90 minutes (Figure 3.6A). Conversely, the PLC activator m-3M3FβS induced an 
increase in PKC activity in the female cells (Figure 3.6B).  Male cells also responded to 
the PLC activator with an increase in PKC, but the effect was seen only at the highest 
concentration (Figure 3.6C). 
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Figure 3.6: Activation of PKC by E2 is dependent on PLC signaling. Confluent, 
fourth  passage resting zone cells  from female rat (A,B) or male rat (c)  were treated for 
90 minutes with 10
-7








 M PLC 
activator  m-3M3FβS (B,C). *P<0.05, treatment vs. control, ^P<0.05, E2 + U73122 vs E2 
alone at a particular concentration of 17β-estradiol. 
 
 PGE2 production in response to E2 was blocked by the PLA2 inhibitor AACOCF3 
(Figure 3.7A).  Activation of PLA2 with PLAA also caused an increase in PGE2 release 
in the female cells (Fig. 3.7B).  Male cells exhibited an increase in PGE2 release when 
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treated with PLAA, but the stimulatory effect was less robust than was observed in the 
female cells (Figure 3.7C). 
 
Figure 3.7: Production of PGE2 by E2 is dependent on PLA2 signaling. Confluent, 
fourth passage resting zone cells from female rat (A,B) or male rat (c) were treated for 90 
minutes with 10
-7









 M PLA2 activator PLAA peptide (B,C). *P<0.05, treatment vs. control, ^P<0.05, E2 
+ ACCOCF3 vs. E2 alone at a particular concentration of E2. 





          This study shows that PKC activity is regulated by E2 in growth plate chondrocytes 
in a sex-specific manner. Only female resting zone chondrocytes exhibited an increase in 
PKC activity when treated with E2. As noted previously, the effects of E2 on PKC are 
membrane-dependent based on the observation that E2-BSA elicits a comparable 
response. E2-BSA has been shown to bind to surface receptors for E2 [73], an remain 
extracellular [152]. Further support that specific receptors are involved is the observation 
that the activation of PKC is stereospecific; only treatment with 17β-estradiol but not 
17α-estradiol resulted in increased enzyme activity. Only E2 but not ent-E2 had an effect 
on PKC activation, this strongly suggests that the effects of E2 are direct and specific to a 
membrane receptor. Thus, the difference in the effect of each enantiomer (E2 and ent-E2) 
on the cell response implies that the binding affinity of E2 to the specific receptor is more 
effective than its enantiomer (ent-E2). 
 Our findings are commensurate with those in other laboratories demonstrating 
that E2 acts via membrane receptors, including ERα and ERβ [70, 108, 113]. Both ERβ 
and ERα selective agonists DPN and PPT activate PKC suggesting that both receptors are 
involved. The fact that ERα [70, 105] and ERβ [106], as well as truncated forms of both 
receptor are present in the plasma membrane [107, 108] and caveolae [109, 110] implies 
that membrane forms of these receptors may play a role.  
In this study we found that E2-induced recruitment of ERs to the plasma 
membrane only in female chondrocytes. The ability of tunicamycin an inhibitor of 
palmitoylacetyltransferase to inhibit the dynamically recruited of ERs from the 
cytoplasmic pool to the plasma membrane and most likely to the caveolae, suggests that 
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posttranslational palmitoylation is required for ERs membrane localization and for E2-
induced recruitment of ERs to the plasma membrane. While in male cells E2 treatment 
decreased the translocation of ERs to the plasma membrane. Furthermore, tunicamycin 
did have any effect.  
This result suggest that, It is possible that by palmitoylation in female 
chondrocytes , ERs are dynamically recruited from the cytoplasmic pool to the plasma 
membrane and most likely to the caveolae, which contains other signaling molecules 
including G protein α-subunits, kinases, and caveolins [114, 153]. The interaction 
between palmitoylated ERs and other caveolae proteins may act as a signal for the 
directional recruitment and restructuring of the receptor. Consequently, ERs were able to 
mediate further stimulation of PKC activity at 90 minutes. Thus, palmitoylation seems to 
be a common regulatory mechanism in the formation of membrane-associated signaling 
complexes [115].  
The ability of downstream PLC activators m-3M3FBS to induce an increase in 
PKC activity in male and female cells, similarly, PLAP peptide downstream PLA2 
activators to induce increase in PGE2 level in both male and female cells, suggests, 
although female chondrocytes expressed more ERα and ERβ on the membrane and 
caveolae fraction than male chondrocytes, they shared similar signaling pathways 
downstream of the receptors. Palmitoylation of the membrane receptor might contribute 







RAPID MEMBRANE RESPONSES TO DIHYDROTESTOSTERONE 
ARE SEX DEPENDENT IN GROWTH PLATE CHONDROCYTES 
 
Introduction 
            Sex steroid hormones have key effects on the development and maintenance of 
the skeleton and its sexual
 
dimorphism [154, 155]. The principle steroidal androgens, 
testosterone (T) and its metabolite 5α-dihydrotestosterone (DHT) play an important role 
in skeletal
 
development in males during adolescence [156]. In certain target tissues such 
as the growth plate, liver, brain, prostate and skin, testosterone is irreversibly converted 
to DHT by the enzyme 5α-reductase [157]. DHT is considered to be the more potent 
hormone because it has a higher androgen receptor binding affinity and a lower 
dissociation constant than testosterone [158]. Androgen deficiency results in various 
abnormalities of bone metabolism, including decreased bone mineral density as well as a 
lower bone mass and accelerated bone loss due to increased bone resorption, leading to a 
higher fracture risk [154]. It was thought that these effects were mainly caused by classic 
nuclear receptors, which act as transcription factors, thereby modulating gene expression 
[159]. However, recent studies indicate that rapid alternative pathways are also involved 
[160, 161]. 
          These rapid responses to androgens occur within seconds to minutes after 
administration of the hormone and are generally insensitive to inhibitors of the androgen 
receptor (AR) [162], suggesting that they are regulated by cellular signaling pathways 
involving surface membrane receptors and second messengers [163]. This mechanism of 
steroid action has been referred to as non-genomic, although they can result in changes in 
downstream gene expression [17]. In cultured cardiac myocytes, testosterone has been 
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found to induce a rapid increase in intracellular Ca
2+
 through activation of a plasma 
membrane androgen receptor associated with the pertussis toxin (PTX)-sensitive G 
protein-coupled phospholipase C (PLC), inositol triphosphate signaling pathway [21, 22]. 
Moreover treatment of LNCaP prostate cells with testosterone coupled to bovine serum 
albumin (T-BSA), which cannot cross the membrane has been shown to cause 
phosphorylation and activation of focal adhesion kinase and increase secretion of 
prostate-specific antigen within minutes [164]. The ability of androgens to rapidly 
modulate the activity of ion channels and Ca
2+ 
has been observed in several cell types 
including endothelial cells [165], breast cancer cells [166], prostate cancer cells [166, 
167], macrophages [168], and T-lymphocytes [169, 170]. Of note, the ability of 
testosterone or T-BSA to increase Ca
2+
 in primary osteoblasts was found to be sexually 
dimorphic [24]. Testosterone was only able to induce Ca
2+
 influx in male primary 
osteoblasts but not those cells derived from females. In contrast, Ca
2+
 influx in female 
osteoblasts was affected by estradiol, in a non-genomic fashion, whereas male osteoblasts 
were estradiol insensitive.  
In long bones, endochondral bone formation occurs at the growth plate, a region 
of developing cartilage located between the epiphysis and the metaphysis [171].  The 
process of endochondral ossification is regulated in part by sex steroid hormones [27]. 
Androgens stimulate endochondral bone growth and elongation [28] while estrogen is 
known to suppress longitudinal bone growth and accelerate growth plate closure [29, 33, 
34, 75, 172-175].  Studies using rat growth plate chondrocytes as a model show that the 
effects of 17β-estradiol (E2) on apoptosis are found in both male and female cells and the 
same mechanism is involved [176].  However, growth plate chondrocytes are also 
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regulated by sex steroids in a sexually dimorphic manner [75].  E2 causes a rapid 
activation of Ca
2+
 influx and activation of PKC only in cells from female rats [75, 174], 
but it is not known if testosterone or DHT has a similar effect on cells from male rats. 
 The goal of the present study was to assess testosterone and / or DHT-dependent 
rapid responses in growth plate chondrocytes and determine the mechanisms involved.  
To do this, we took advantage of the rat costochondral cartilage chondrocyte model in 
which cells at distinct states of endochondral development can be isolated and cultured in 
vitro up to four passages without loss of phenotype [177].  Chondrocytes from the resting 
zone of the growth plate were treated with testosterone and DHT, and rapid effects on 
phospholipase A2 (PLA2) and PKC signaling pathways determined. 
Materials and Methods 
Reagents 
            5α-Dihydrotestosterone (DHT); testosterone; G-protein inhibitor pertussis toxin 
(PTX, Gαi inhibitor) [178], cholera toxin (CTX, Gαs activator) [179], and GDPβs 
(general G-protein inhibitor) [180, 181]; and PLA2 inhibitors AACOCF3 [182] and 
quinacrine [183] were obtained from Sigma Chemical Co. (St. Louis, MO). Thapsigargin 
as an inhibitor of a Ca-ATPase pump in the endoplasmic reticulum [184], and verapamil 
hydrochloride as well as nifedipine an inhibitors of specific L type Ca
2+ 
channels on the 
cell membrane [185, 186], actinomycin D [187] and the translation inhibitor 
cycloheximide [188, 189] were purchased from Sigma Chemical Co. (St. Louis, MO). 
U73122 (phospholipase C inhibitor) [190] was obtained from Cayman Chemical (Ann 
Arbor, MI). A PKC assay kit was obtained from Amersham Bioscience (Piscataway, NJ) 
and Dulbecco’s modified Eagle medium (DMEM) was obtained from GIBCO-BRL 
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(Gaithersburg, MD). The protein content of each sample was determined using the 





H]-thymidine were obtained from Perkin Elmer 
(Melville, NY). 
Chondrocyte Cultures 
The culture system used in this study has been described in detail previously [88]. 
Chondrocytes were isolated from the resting zone of costochondral junction of 150 g 
male and female Sprague-Dawley rats. To limit the contamination by fibroblasts and 
osteoblasts, perichondrium tissue and calcified cartilage were discarded. After dissection, 
the cartilage was sliced and incubated overnight in DMEM in a 5% CO2 atmosphere and 
100% humidity at 37
o
C for 24h.  Chondrocytes were released from the tissue by 
sequential incubations in 1% trypsin for 1 h and in 0.02% Type II collagenase for 3 h in 
Hanks’ balanced salt solution. Chondrocytes were plated at an initial density of 10,000 
cells/cm
2
. Cells were incubated in DMEM containing 10% fetal bovine serum (FBS) and 
50 μg/ml vitamin C in atmosphere of 5% CO2 and 100% humidity at 37
o
C. The culture 
media were replaced after 24 h and then at 72 h until cells reached confluence.  Fourth 
passage cells were used for all experiments based on previous studies showing that these 
cells preserve their chondrogenic phenotype as well as their differential responsiveness to 
vitamin D metabolites at this passage [89].  
Protein Kinase C 
In order to determine if testosterone or DHT cause rapid activation of PKC, 
confluent fourth passage male and female cells in 24 well plates were treated for different 
time periods with 0.5 ml of ethanol at highest concentration used in experimental cultures 
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or experimental media (DMEM + 10% FBS + various concentrations of testosterone or 
DHT). Experimental time points 9, 90 and 270 min were examined. After the incubation 
period, cell layers were washed with PBS to remove any excess media and then lysed in 
solubilization buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA,1 mM 
phenylmethylsulfonylflouide and 1% NP-40). 25µl of the cell lysates were assayed for 
protein content [87]. PKC activity was measured in cell lysates using a kit following the 
manufacturer’s directions (Amersham Bioscience).  This kit is optimized for 
measurement of phospholipid and Ca
2+
-dependent PKC [92, 191]. 
Mechanism of PKC Activation 
Phospholipase A2 
To assess the effects of testosterone and DHT on PLA2 activity, the following 
protocol was used. For each experiment, confluent cultures of male chondrocytes in 24 
well plates were treated for 9 minutes with 0.5 ml of the control media (0.02% ethanol in 
DMEM + FBS) or experimental media (DMEM + 10% FBS + various concentrations of 
testosterone or DHT).  After the treatment period, cell layers were washed with 
phosphate buffered saline (PBS) and then cells were sonicated in 0.1 ml of cold buffer 
(50 mM 4-2 hydroxyethyl-1-piperazineethane sulfonic acid containing 1 mM EDTA). 
Cell pellets were obtained by centrifugation for 15 minutes. 25µl of the cell lysates were 
assayed for protein content [87]. PLA2 activity was measured in cell supernatant using a 
kit following the manufacturer’s directions (VWR). Samples were analyzed using a plate 
reader at 414 nm [93, 94, 192]. To verify the role of PLA2, the secretory PLA2 inhibitor 
quinacrine [183] or the cytosolic PLA2 inhibitor AACOCF3 [182] were used to inhibit 
PLA2 activity. Cultures were incubated for 9 minutes with control media or 10
-7
 M DHT 
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in the presence or absence of 0.1 or 1 or 10 µM quinacrine or AACOCF3 and assayed for 
PKC activity.   
Phospholipase C 
Involvement of PLC was examined using U73122, an inhibitor of 
phosphatidylinositol (PI)-specific PLC [190]. Cultures were incubated for 9 minutes with 
the control media or 10
-7
 M DHT in the presence or absence of 0.1, 1 or 10 μM U73122, 
and PKC specific activity was determined [87, 89]. 
 G-Proteins 
To examine the role of G-proteins, the nonhydrolyzable GDPβs [180, 181] 
(general G-protein inhibitor), cholera toxin (CTX, Gαs activator) [179, 193] and  
pertussis toxin (PTX, Gαi inhibitor) [15] were used.  Cultures were treated for 9 minutes 
with control media or 10
-7
 M DHT in the presence or absence of 1 or 10 µM PTX or 





M DHT in the presence or absence of 0.1 μM GDPβs. 
Intracellular Ca2+ 
In order to determine the source of the intracellular calcium involved in the non-
genomic mechanisms in PKC activation, we used three different inhibitors.  Thapsigargin 
is an inhibitor of a Ca-ATPase pump in the endoplasmic reticulum [184]. The cultures 
were incubated for 30 min with 0.1 or 1 µM thapsigargin prior to treatment with DHT in 




 M DHT was then added for 9 minutes and the 
cultures lysed and assayed for PKC activity.  The same strategy was used with two 
inhibitors of L type Ca
2+
 channels on the cell membrane: verapamil and nifedipine [185, 
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186].  Cultures were pretreated with 1 or 10 µM verapamil or nifedipine for 30 minutes 
and then with DHT for 9 minutes.  Cell layer lysates were assayed for PKC activity. 
Androgen Receptor 
The role of the classical androgen receptor in the effect of DHT on PKC was 
examined using cyproterone acetate (CPA) to inhibit receptor binding [194].  Male 




 M DHT in the 
presence or absence of 0.1 µM CPA. 
Requirement for Transcription and Translation 
To examine the involvement of genomic mechanisms in PKC activation, the 
chondrocyte cultures were treated with DHT in the presence of the transcription inhibitor 
actinomycin D [187] or the translation inhibitor cycloheximide [188, 189]. Cultures were 
incubated with 10
-7 
M DHT and 0.1 mM actinomycin D or 0.1 mM cycloheximide for 9 
min. After treatment with the inhibitors, the cells were washed with PBS and assayed for 
PKC activity as described above. 
Role of PKC in Mediating the Physiologic Response to DHT 
 [3H]-Thymidine Incorporation 
DNA synthesis was tested by measuring [
3
H]-thymidine incorporation into 
trichloroacetic acid (TCA) insoluble cell precipitates as described previously [89]. 
Cultures of male resting zone chondrocytes were incubated for 48 h with DMEM 
containing 1% FBS in order to achieve quiescence. The media were replaced with control 
media or 10
-7
 M DHT for 9 minutes, at which time the media were replaced with DMEM 
containing 1% FBS for 24 h. Four hours prior to harvest, [
3
H]-thymidine (2 μCi/ml) was 
added. At harvest, the cell layers were washed twice with cold PBS and twice with TCA, 
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then treated with saturated TCA for 30 min. TCA-perceptible material was dissolved in 
0.2 ml 1% sodium dodecyl sulfate, and radioactivity was measured by liquid scintillation 
spectroscopy. 
Alkaline Phosphatase Specific Activity 
To examine the effect of DHT on alkaline phosphatase activity, confluent cells 




 M DHT for 9 minutes. 
After 9 minutes, the media were replaced with DMEM containing 1% FBS for 24 hours. 
Alkaline phosphatase [orthophosphoric monoester phosphohydrolase, alkaline] specific 
activity was measured in the cell layers lysates as a function of release of para-
nitrophenol from para–nitrophenylphosphate at pH 10.2 [195] and normalized to protein 
content [87]. 
Phospholipase C 
The involvement of PLC was examined using U73122. Cultures were incubated 
for 9 minutes with control media or 10
-7
 M DHT in the presence or absence of 0.1 μM 
U73122.  Alkaline phosphatase was assayed at 24 hours as described above.  
Statistical Analysis 
For each experiment, each data point represents the mean±SEM for six individual 
cultures (cell layers). Significance between groups was determined by Bonferroni’s 
modification of Student’s t-test using *P<0.05. Each experiment was repeated two or 






Protein Kinase C 
Testosterone had no effect on PKC in male chondrocytes at any of the times tested (Fig. 
1A), whereas DHT caused a rapid increase in PKC activity at 9 minutes that was still 
present at 90 minutes (Figure 4.1B). Neither testosterone nor DHT affected PKC activity 
in female resting zone chondrocytes (Figure 4.1C, D). Testosterone failed to stimulate 
PKC activity in the male cells at any of the concentrations tested (Figure 4.1E). In 









Figure 4.1: Time- and dose-dependent effects of DHT on PKC specific activity of 
confluent, fourth passage rat resting zone chondrocytes. Time-dependent response of 
male rat chondrocytes was evaluated at 3, 9, 90 and 270 minutes with control media or 
media containing 10-7 M testosterone (4.1A) or media containing10-7 M DHT (4.1B). 
The same experimental design was used with female rat chondrocytes to evaluate the 
time-dependent effects of testosterone (4.1C) and DHT (4.1D). Because DHT had an 
effect only on male rat chondrocytes, the dose-dependent response was assessed in male 
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rat chondrocytes treated for 9 minutes with control media or media containing 
concentrations ranging from 10-10 to 10-7 M testosterone (4.1E) or DHT (4.1F). Data 
show the mean ± SEM for six independent cultures from one representative experiment. 
*P<0.05, DHT treatment vs. control, ^P<0.05 10-10 M vs. 10-9—10-7 M DHT., #P<0.05 
10-9 M vs. 10-8—10-7 M DHT. 
 
Mechanism of DHT-dependent PKC Activation 
Phospholipase A2 
Testosterone had no effect on activation of PLA2 activity in male chondrocytes (Figure 
4.2A). In contrast, the effect of DHT was dose-dependent, significant from 10-9 to 10-7 
M DHT, with a maximal effect at 10-7 M (Figure 4.2B). Regulation of PKC activity by 
DHT is PLA2-dependent and both secretory and cytosolic isoforms are involved. The 
secretory PLA2 inhibitor quinacrine caused dose-dependent decrease in DHT-dependent 
PKC activity (Figure 4.2C). Similarly, the cytosolic PLA2 inhibitor AACOCF3 blocked 
PKC activity caused by DHT (Figure  4.2D). 
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Figure 4.2: PLA2 activation and its role in DHT-dependent PKC activity in 
confluent, fourthpassage rat resting zone chondrocytes. PLA2 activation was 
measured on male rat chondrocytes treated for 9 minutes with control media or media 




 M testosterone (4.2A) or DHT 
(4.2B). Additionally, PKC specific activity was assayed in male rat chondrocytes treated 
with control media or media containing 10
-7
 M DHT in the presence or absence of 0.1, 1 
or 10 μM quinacrine (secretory-PLA2 inhibitor) (4.2C) or AACOCF3 (cytosolic-PLA2 
inhibitor) (4.5D). Data show the mean ± SEM for six independent cultures from one 




 Phospholipase C 
The PI-PLC inhibitor U73122 had no effect on basal PKC activity; however it inhibited 
PKC activity in DHT-treated male chondrocytes at 10-5 M (Figure 4.3A). 
G-Proteins 
G-proteins mediated the effect of DHT on PKC. The nonhydrolyzable G-protein inhibitor 
GDPβS blocked DHT-stimulated PKC activity in male resting zone chondrocytes, but 
had no effect on the basal level activity of PKC (Figure 4.3B). Cultures treated with 10-6 
or 10-5 GDPβs inhibited the DHT effect on PKC activity completely. 10-6 M cholera 
toxin, the activator of Gαs, completely blocks the DHT effect on PKC activity (Figure 
4.3C). Similarly, 10-6 and 10-7 M of the Gαi inhibitor pertussis toxin blocked PKC 
activity completely (Figure 4.3D). Moreover higher concentrations of PTX (10-6 M) 




Figure 4.3: Effect of phospholipase C inhibitor U73122 or G-protein inhibitors on 
DHT-dependent PKC specific activity of confluent, fourth-passage rat resting zone 
chondrocytes. Male rat chondrocytes were treated for 9 minutes with control media or 
media containing 10-7 M DHT in the presence or absence of 0.1, 1 or 10 μM U73122 
(4.3A). Alternatively, cultures were treated with DHT in the presence or absence of 1 or 
10 μM non-hydrolyzable GDPβS (general G-protein inhibitor) (4.3B), 0.1 or 1 μM 
cholera toxin (CTX, Gαs activator) (4.3C), and 0.1or 1 μM pertussis toxin (PTX, Gαi 
inhibitor) (4.3D). Data show the mean ± SEM for six independent cultures from one 
representative experiment. *P<0.05, DHT treatment vs. control; ^P<0.05 treatment vs. 
different inhibitors. 
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Source of Intracellular Calcium 
DHT induced PKC activity via two mechanisms: influx of extracellular Ca2+ via voltage 
gated calcium ion channels, and Ca2+ mobilization from the endoplasmic reticulum. 
Thapsigargin abolished the effect of DHT on PKC activity on a dose dependent manner 
(Figure 4.4 A). Similarly, pre-incubation of resting zone chondrocytes from male rats 
with 0.1 or 1 or 10 μM verapamil (Figure 4.4B) or nifedipine (Figure 4.4C) decreased 
PKC activity to baseline levels. 
 
Figure 4.4: Calcium sources involved in DHT-induced PKC activity of confluent, 
fourth-passage male rat resting zone chondrocytes. Chondrocytes were treated for 9 
minutes with control media or media containing 10-7 M DHT in the presence or absence 
of 1 or 10 μM thapsigargin (inhibitor of Ca-ATPase pumps in the endoplasmic reticulum) 
(4.4A). Additionally, cultures were treated with DHT in the presence or absence of 0.1 or 
1 μM verapamil ( 4.4B) and 0.1 or 1 μM nifedipine (specific inhibitors of L-type Ca2+ 
channels on the cell membrane) (4.4C). Data show the mean ± SEM for six independent 







Role of Classical Androgen Receptors 
The activation of PKC by DHT in growth plate chondrocytes isolated from male rats did 
not depend on classical nuclear androgen receptors (Figure 4.5A). PKC activity was not 
significantly changed in cultures treated with 10-7 M CPA. Moreover, this compound did 
not affect basal PKC activity. 
Role of Genomic Mechanisms in PKC Activation 
Pre-incubation of chondrocytes from male rats with the inhibitor of DNA transcription 
actinomycin D or the inhibitor of protein synthesis cycloheximide did not affect the 
ability of DHT to stimulate PKC activity (Figure 4.5 B,C). 
 
Figure 4.5: The role of androgen nuclear receptor and protein synthesis in DHT-
induced PKC activity of confluent, fourth-passage male rat resting zone 
chondrocytes. Chondrocytes were treated for 9 minutes with control media or media 
containing either 10-8 or 10-7 M DHT in the presence or absence of 10 μM cyproterone 
acetate (CPA, inhibitor of classical androgen receptor) (4.5A). Additionally, cultures 
were treated with 10-7 M DHT in the presence or absence of 10 μM cycloheximide 
(inhibitor of protein biosynthesis) (4.5B) or 10 μM actinomycin D (pharmacological 
inhibitor of DNA transcription) (4.5C). Data show the mean ± SEM for six independent 





Role of PKC in the Physiological Response to DHT 
DNA Synthesis  
DNA synthesis was not regulated by DHT. Treatment with DHT for 9 minutes had no 
effect on [3H]-thymidine incorporation by resting zone chondrocytes from male rats at 
any  concentration tested (Figure 4.6A). 
Alkaline Phosphatase Specific Activity 
DHT regulated alkaline phosphatase in male resting zone chondrocytes. Addition of DHT 
for only 9 minutes caused a dose-dependent activation of alkaline phosphatase specific 
activity, significant at 10-8-10-7 M, with the highest peak at 10-7 M (Figure 4.6B). The 
regulation of alkaline phosphatase specific activity by DHT was mediated by PI-PLC 
since the specific inhibitor U73122 abolished the DHT effect (Figure 4.6B). 
 
Figure 4.6. Effect of DHT on DNA synthesis and alkaline phosphatase activity of 
quiescent, fourthpassage male rat resting zone chondrocytes. Cells were treated for 9 
minutes with 10-9 to 10-7 M DHT. To measure DNA synthesis, [3H]-thymidine was 
added 20 hours after DHT treatment and 4 hours prior to harvest (Fig. 6A). Alkaline 
phosphatase specific activity was measured in cell layer lysates 24 hours after DHT 
treatment in the presence or absence of 0.1 μM PI-PLC inhibitor U73122 (Fig. 6B). Data 
show the mean ± SEM for six independent cultures from one representative experiment. 





Figure 4.7: Proposed mechanism of DHT signaling in male resting zone growth 
plate chondrocytes. DHT exerts its effects through activation of a membrane-associated 
receptor (R). Stimulation of this membrane receptor initiates Gαi (G) mediated PLA2 
activation and PLC signaling pathway. A consequence of this signaling is production of 
inositol 1,4,5-trisphosphate (IP3) and DAG. IP3 causes an increase in the release of Ca2+ 
from the endoplasmic reticulum (ER). Free Gβγ subunits produced from G-protein 
activation lead to an increase in Ca2+ influx via L-type calcium channels. Both DAG 
produced as a consequence of PLC activity and increase in intracellular Ca2+ activate 
PKC on the plasma membrane. Increase in cytosolic Ca2+ as well as the stimulation of 
Gαi leads to PLA2 activation and release of lysophospholipids (Lyso), which can also 
increase PLC activity. Once PKC is activated, it can initiate a protein phosphorylation 
cascade that ultimately affects cell differentiation. 
 
Discussion 
This study demonstrates that DHT regulates growth plate chondrocytes in a sex-
specific manner via rapid signaling pathways. The effects of DHT were observed only in 
chondrocytes from male rat growth plates and occurred within 9 minutes.  Both PKC and 
PLA2 were activated in a dose-dependent manner and increases in activity were seen at 
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physiologically relevant concentrations. No effect of the testosterone metabolite was 
observed in the female cells. Moreover, the results show that the stimulatory effects on 
these two signaling pathways were specific to DHT and not testosterone as testosterone 
had no effect on either enzyme activity. 
           Neither gene transcription nor translation were required for DHT-
dependent PKC activation to occur, indicating that DHT stimulated existing enzyme. We 
did not determine which PKC isoform was sensitive to DHT, but the assay conditions 
that were used are optimized to isoforms sensitive to both Ca
2+
 ions and phospholipids, 
suggesting a role for PKC [196, 197].  
 CPA, which competes with testosterone and DHT to bind to the androgen 
receptor, did not inhibit the rapid responses, suggesting that DHT regulates PKC via a 
specific receptor that is different than the classic nuclear receptor. T-BSA which can not 
enter the cell, also failed to activate PKC, indicating that testosterone dose not participate 
via a membrane form of AR and suggesting that DHT’s effect is also via membrane AR.  
It is likely that the DHT-receptor is membrane-associated, however, as DHT stimulated 
PKC by mechanisms that are membrane-mediated.  
The DHT-receptor might be a G-protein coupled receptor, as our results showed 
that G-protein is required for DHT-dependent PKC activation. There are two classes of 
G-proteins that couple receptors to the activation of PI-PLC: one that is PTX-sensitive 
and one that is PTX-insensitive [198]. Pre-incubation of chondrocytes with both PTX 
(Gαi inhibitor) and CTX (Gαs activator) completely blocked the stimulatory effect of 
DHT on PKC activity. In other systems, upon G-protein activation, Gα disassociates from 
Gβγ, which can then activate Ca
2+
 ion channels on the plasma membrane [199]. Our 
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results show that DHT stimulates influx of extracellular Ca
2+ 
ions. Moreover, inhibition 
of Ca
2+ 
influx blocks the stimulatory effect of DHT on PKC. Gα proteins have also been 
shown to activate PI-PLC [200],[201] and PLC was required for DHT-dependent PKC 
activation, since specific inhibition of PI-PLC blocked activation of PKC by DHT. 
Moreover, inhibition of release of Ca
2+
 ions from the endoplasmic reticulum also reduced 
DHT‘s effect. PI-PLC catalyzes the release of IP3, which opens these Ca
2+ 
ion channels 
and resulting DAG translocates the active PKC to the plasma membrane. Although Gαq 
is generally associated with PI-PLC activation [202], Gαi has also been shown to do so 
[182].  
 It is also possible that Gαi is activating PLA2, and that is upstream of PI-
PLC, as we have shown for 1α,25-dihydroxy vitamin D3–dependent activation of PKC in 
growth plate chondrocytes [203]. Our results show that DHT activated PKC via a PLA2-
dependent pathway. DHT caused a rapid increase in PLA2 activity and inhibition of 
PLA2 blocked the stimulatory effect of DHT on PKC. Production of lysophospholipid 
[204] and release of arachidonic acid [205] are catalyzed by PLA2 via phospholipid 
hydrolysis. Arachidonic acid can act as co-factor for PKCα and also provides a substrate 
for constitutively active cyclooygenase-1 (Cox-1) in growth plate chondrocytes, which 
leads to prostaglandin production. In addition, lysophospholipid can activate PLC [203], 
and can then initiate the downstream PLC-PKC pathway (Fig. 7).  
 Our results demonstrate that DHT regulates proliferation and 
differentiation of growth plate chondrocytes by multiple mechanisms. The fact that 
U73122 blocked the stimulatory effect of DHT on alkaline phosphatase activity suggests 
that rapid membrane response via the PLC-PKC pathway plays an important role in 
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differentiation of male chondrocytes. In contrast, DNA synthesis is not regulated in this 
manner.  We previously showed that testosterone and DHT can regulate proliferation 
[33]; however, in the present study, a 9 minute pulse of DHT had no effect on [
3
H]-
thymidine incorporation, indicating that the proliferative effects of testosterone and/or 
DHT are likely mediated by the classic androgen receptor.  
 Rat growth plate chondrocytes possess 5α-reductase and convert 
testosterone to DHT [33, 172], and regulation of these cells by testosterone is dependent 
on the production and release of DHT [172]. Here we show that DHT but not testosterone 
elicits the rapid membrane response. Taken together, this suggests that the membrane-
associated effects of androgens are mediated by paracrine actions of DHT.  
 In summary, DHT regulates male resting zone chondrocytes through rapid 
activation of a membrane-associated receptor. This results in PLA2 and PLC-mediated 
activation of PKC and increase in chondrocyte differentiation. These findings indicate the 
importance of the membrane effects as mediators of DHT action in chondrocytes and 













INVOLVEMENT OF RECEPTORS FOR ANDROGEN AND ESTROGEN IN 




 Androgen receptors (ARs) and estrogen receptors (ERs) are found together in 
many tissues, and their interactions may be responsible for a variety of physiological 
effects including normal development as well as pathology [206]. However, their 
interaction at the molecular level has been largely undefined [207]. Estrogens and 
androgens interact in prostate cells to modulate androgen actions [208]. One possibility is 
that estrogens and androgens induce assembly of a ternary complex. In LNCaP prostate 
adenocarcinoma cells, this complex is hypothesized to consist of the AR, ERβ and Src 
[209]. Its formation can be triggered by 17β-estradiol or by the synthetic androgen 
methyltrienolone (R1881), which activates Src-dependent S-phase entry and cell 
proliferation. The AR antagonist Casodex inhibits this effect, further supporting the 
hypothesis of an ER/AR complex. 
Two natural potent androgens, testosterone and its metabolite dihydrotestosterone 
(DHT), are found in humans and mammals [10]. Both androgens interact with the AR to 
regulate androgen-target gene expression. DHT, which is converted from testosterone by 
5α-reductase isozymes, is the major intracellular androgen and the major mediator of 
androgen actions in the prostate [11]. Like other steroid hormones, testosterone and DHT 
bind to intracellular ARs,. inducing receptor dimerization. This facilitates the ability of 
ARs to bind to DNA and recruit coregulators to promote or suppress the expression of 
target genes [12, 13]. This mechanism of steroid action is known as the classical or 
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genomic pathway and because it involves gene transcription and mRNA translation, its 
effects may take several hours to days to be seen [14].  
In addition to their genomic actions, it is now understood that steroid hormones 
can also exert actions that are insensitive to inhibitors of transcription and translation and 
occur within seconds to minutes after administration of the hormone [15, 16]. This 
mechanism of steroid action is referred to as non-genomic or non-classical and may result 
in changes in downstream gene expression via membrane-associated signaling pathways 
[17, 18]. Several studies show that these rapid effects of androgens are mediated by 
cellular signaling pathways involving surface membrane receptors and second 
messengers [19, 20]. In cultured cardiac myocytes, testosterone has been found to induce 
a rapid increase in intracellular Ca
2+
 through activation of a plasma membrane AR 
associated with the pertussis toxin (PTX)-sensitive G protein-coupled phospholipase C 
(PLC), inositol trisphosphate (IP3) signaling pathway [21, 22]. Similarly DHT induces 
protein kinase C (PKC) activity via a PLC dependent pathway [23].  
Sex steroids can elicit sex-specific effects in their target cells via membrane 
associated mechanisms. The ability of testosterone or testosterone coupled to bovine 
serum albumin (T-BSA), which cannot cross the membrane, to increase Ca
2+
 in primary 
osteoblasts is found only in cells from male rats but not from female rats [24]. 
Importantly, the rapid effect of androgens on PKC in costochondral cartilage cells is 
specific to DHT and is found only in chondrocytes from male animals. Testosterone does 
not induce this response in cells from rats of either sex. Estrogens also regulate cells by 
rapid membrane associated signaling pathways in addition to classical ER-dependent 
mechanisms [25] and some of the membrane-associated effects are sex-specific [24]. 
 64 
Rat growth plate chondrocytes possess ARs, ERα and ERβ [74, 75, 210] and 
recent studies show that ERα is present in the plasma membrane in different molecular 
forms: the traditional 68kDa nuclear form (ERα68), a 46kDa form (ERα46) and a 36kDa 
form (ERα36) [45]. ERα36 is responsible for some of the rapid actions of estrogen that 
are mediated by membrane associated signaling pathways [211]. An AR splice variant 
was recently identified in the plasma membrane of prostate cancer cells [212]. It lacks a 
DNA binding domain and therefore, may not function as a transcription factor on its own 
but it may contribute to the membrane associated response to DHT. Because ARs and 
ERs do not possess an intrinsic transmembrane domain [76], it is likely that they interact 
with specific membrane protein(s) in order to associate with the plasma membrane [77, 
78]. Caveolin-1 has been implicated as has palmitoylation as a mechanism for locating 
ERs at the plasma membrane [72, 73]34], suggesting that similar mechanisms are 
involved in AR translocation. 
 In long bones, endochondral bone formation occurs at the growth plate, a region 
of developing cartilage located between the epiphysis and the metaphysis [171]. The 
process of endochondral ossification is regulated in part by sex steroid hormones [27]. 
Androgens stimulate endochondral bone growth and elongation [28, 213], while estrogen 
is known to suppress longitudinal bone growth and accelerate growth plate closure [29, 
33, 34, 75, 172-175]. Studies using rat costochondral growth plate chondrocytes as a 
model show that the effects of 17β-estradiol (E2) on apoptosis are found in both male and 
female cells and the same mechanism is involved [176]. In contrast, E2 causes rapid 
activation of PKC in female cells but not in male cells. DHT also has direct effects on 
growth plate chondrocytes, increasing matrix synthesis including sulfated 
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glycosaminoglycan production [214], and enhancing cell maturation by increasing 
alkaline phosphatase enzymatic activity [23]. Moreover, these effects of DHT are sex-
specific and depend on rapid PKC dependent signaling [23]  
 The goal of this study was to investigate the role of the ARs and ERs in the rapid 
membrane-associated actions of DHT, using sex-specific DHT-dependent stimulation of 
PKC in male rat costochondral cartilage cells as a model. Differences in response to DHT 
and its enantiomer ent-DHT were used to determine if DHT acts via direct receptor 
binding or indirect membrane perturbation effects [215]. We used selective agonists and 
antagonists of the AR, as well as specific blocking antibodies for ERα and ERβ to 
determine if one or both receptors mediate the response. We assessed the plasma 
membrane location of the receptors by determining whether they co-localize with 
caveolin-1 (Cav-1) and if intact caveolae are required for the response. We determined if 
palmitoylation or myristylation of the receptor(s) is involved in targeting the receptor(s) 
to the plasma membrane. Finally, we assessed the role of the AR in regulating growth 
plate chondrocyte maturation by determining the effect of DHT-dependent signaling on 
[
35
S]-sulfate incorporation.  
Materials and Methods 
Reagents 
 5α-Dihydrotestosterone (DHT) and methyl-β-cyclodextrin (β-CD) were obtained 
from Sigma Chemical Co. (St. Louis, MO). Anti-ERα monoclonal antibody (ab16460), 
anti-ERβ monoclonal antibody (ab16813), non-specific IgG (ab91353), and non-specific 
IgM (ab91545) were purchased from Abcam (San Francisco, CA). A polyclonal antibody 
to Cav-1 was purchased from Santa Cruz Biotechnology (sc-894, Santa Cruz, CA) The 
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AR inhibitor bicalutamide (Casodex) [216] was obtained from Tocris Cookson, Inc. 
(Ellisville, MO). Tunicamycin, an inhibitor of palmitoylacetyltransferase [113], was 
purchased from EMD Chemicals, Inc. (San Diego, CA). 2-Hydroxymyristic acid (HMA), 
a myristate antagonist [113], was obtained from Cayman Chemical (Ann Arbor, MI). A 
PKC assay kit was obtained from Amersham Bioscience (Piscataway, NJ) and 
Dulbecco’s modified Eagle medium (DMEM) was obtained from GIBCO-BRL 
(Gaithersburg, MD). The protein content of each sample was determined using the 
bicinchoninic acid (BCA) protein assay kit [87] obtained from Pierce Chemical Co. 
(Rockford, IL). [
32
P]-ATP; the synthetic androgen, methyltrienolone R1881; and [
35
S] 
were obtained from Perkin Elmer (Melville, NY). 
Chondrocyte Cultures 
 The culture system used in this study has been described in detail previously 
[147]. Chondrocytes were isolated from the resting zone cartilage of the costochondral 
junction of 150g male Sprague-Dawley rats. The cells were cultured in DMEM 
containing 10% fetal bovine serum (FBS) and 50 μg/ml sodium ascorbate in an incubator 
at 5% CO2 and 100% humidity at 37
o
C. Fourth passage cells were used for all 
experiments based on previous studies showing that these cells preserve their 
chondrocyte phenotype as well as their differential responsiveness to vitamin D 
metabolites at this passage [89]. 
Regulation of Protein Kinase C Activity 
 Initial experiments determined the receptor(s) involved in regulation of PKC 
activity by DHT. Confluent cultures were treated for 9 minutes either with vehicle alone 
(0.5 ml of ethanol at highest concentration used in experimental cultures) or experimental 
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media (DMEM + 10% FBS + various concentrations of ent-DHT [54] or R1881). 
Cultures were treated with (DMEM + 10% FBS + 10
-7
M DHT) as the positive control 
[23]. The contribution of ARs to any change in PKC activity was determined by pre-
incubating cells for 30 minutes with 10
-5




 To determine the involvement of ERs in this pathway, cells were pre-incubated 
for 30 minutes with 1:500 v/v dilution of non-specific antibodies IgG and IgM or with 
specific monoclonal antibodies to ERα and ERβ, respectively. At the end of the pre-
incubation, the cells were treated for 9 minutes with vehicle alone or with 10
-7
M DHT. 
Although these monoclonal antibodies were generated to intracellular ERs, they have 
been used successfully to label protein in the plasma membrane [217]. To assess the role 
of palmitoylation or myristylation of AR in regulating PKC activity, cells were pre-
incubated for 2 hours with 30μM tunicamycin [218] or with 0.5mM 2-hydroxymyristic 
acid (HMA) [218], and then with 10
-7
 M DHT for 9 minutes. 
Requirement for Caveolae  
 To determine if the DHT-dependent increase in PKC requires caveolae, cultures 
were pre-incubated for 30 minutes with 5mM β-CD in order to disrupt the caveolae by 
depleting them of cholesterol [72, 140]. Cells were then treated for 9 minutes with 10
-7
 M 
DHT as described previously [140]. In order to verify that ARs are present in caveolae, 
we used a detergent-free method to isolate and fractionate plasma membranes. 
Chondrocytes were treated with either 10
−7
M DHT or vehicle for 9 minutes. The cells 
layers were washed two times with phosphate buffered saline and the cells were 
harvested by scraping using isolation buffer (0.25M sucrose, 1mM EDTA, 20mM tricine, 
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pH 7.8). The cells were homogenized using a tissue grinder and the homogenate was 
centrifuged at 20,000 x g for 10 minutes. The pellet, including nuclei, mitochondria, and 
endoplasmic reticulum was discarded. The supernatant was collected and placed on top 
of isolation buffer containing 30% Percoll (GE Healthcare, Piscataway, NJ). After 
centrifuging at 84,000 x g for 30min, the plasma membrane fraction appeared as a visible 
band in the middle of the centrifuge tube. This fraction was layered over a 10–20% 
OptiPrep gradient (Sigma–Aldrich), and the gradient was centrifuged at 52,000 x g for 
another 4 hours. Plasma membrane sub-fractions were collected from the top to the 
bottom of the tube, which resulted in isolation of 15 fractions. Caveolae were observed as 
an opaque band, which was collected in fraction 3, based on enrichment in caveolin-1 by 
western blot analysis. 
 Whole cell lysates, plasma membranes and the caveolae fraction 3 were separated 
on 4-20% gradient acrylamide gels. Blots of the gels were probed with the rabbit 
monoclonal antibody against AR (ab16460) and rabbit polyclonal antibody against Cav-
1. Immunoreactive bands were visualized using goat anti-rabbit horseradish peroxidase-
conjugated secondary antibodies (Bio-Rad, Hercules, CA). The Super Signal West Pico 
Chemiluminescent System (Thermo Fisher Scientific) was used to treat the membrane, 
which was then imaged with the VersaDoc imaging system (Bio-Rad). 
Role of ARs in Chondrocyte Response to DHT  
 Previous studies show that DHT stimulates [
35
S]-sulfate incorporation by rat 
costochondral cartilage cells [174]. To determine if this effect is mediated by the AR via 
membrane associated signaling pathways, we first determined if transient exposure to 




M DHT was added to confluent cultures for 9 
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minutes. The media were removed and fresh media were added for 24 hours. Four hours 
prior to harvest, 50 μl DMEM containing 18 μCi/ml [
35
S]-sulfate and 0.814 mM carrier 
sulfate were added to each culture. At harvest, the conditioned media were removed, the 
cell layers (cells and matrix) collected, and the amount of [
35
S]-sulfate incorporation 
determined as a function of protein  in the cell layers [87]. 
 To determine if the effect of DHT on [
35
S]-sulfate incorporation was mediated by 
the AR, confluent cultures were pre-incubated with the AR inhibitor 10
-5
M Casodex for 




 M DHT for 9 minutes. The same strategy was used to 
assess the involvement of PLC. Cells were pre-incubated for 30 minutes with 10
-5
 M 




 M DHT 
for 9 minutes. Experimental media were removed and fresh media were added for 24 
hours. 
Statistical Management of the Data 
 For each experiment, each value represents the mean ± SEM of the cell layers of 
six independent cultures. Statistical significance was determined by ANOVA, followed 
by Bonferroni’s modification of Student’s t-test. P<0.05 was considered significant. Each 
experiment was repeated two or more times to ensure the validity of the results. The data 
presented are from a single representative experiment.  
Results  
 The effect of DHT on PKC is receptor-mediated. Only DHT, but not ent-DHT, 
caused a concentration dependent increase in PKC specific activity in male cells (Figure 
5.1A). The AR is involved in the mechanism. The selective AR agonist R1881 activated 
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PKC (Figure 5.1B), whereas the AR specific antagonist Casodex completely abolished 




Figure 5.1: Dose-dependent effect of ent-DHT, R1881 and role of AR in PKC specific 
activity in male resting zone chondrocytes. Dose dependent effects were determined by 








 M R1881 
(B), or with or 10
-7
 M DHT as a positive control. Role of AR was tested by treating the 
cells for 9 minutes with 10
-7
 M DHT ± 10
-5
 M casodex (C). PKC specific activity was 
measured in cell layer lysates. Values are the mean±SEM for six independent cultures for 
each variable. *P<0.05, treatment vs. control at each time point.  
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ERs also play a role in mediating the effect of DHT on PKC.  Antibodies to either ERα 
(Figure 5.2A) or ERβ (Figure 5.2B) completely blocked DHT-dependent activation of 
PKC, whereas IgM and IgG had no effect.  
 
 
Figure 5.2: Involvement of ERα and ERβ in DHT-mediated PKC activity. Confluent 
male resting zone chondrocytes were pre-incubated for 30 minutes with anti-ERα 
antibody (A) or anti-ERβ antibody (B). Cells were then treated with 10
-7
 M DHT for 9 
minutes. PKC specific activity was measured in cell layer lysates. Values are the 
mean±SEM for six independent cultures for each variable. *P<0.05, treatment vs. control, 
^P<0.05, DHT+ anti-ERα vs. DHT alone or DHT + anti-ERβ vs. DHT alone for each 
experiment. 
 
The mechanism by which the AR mediates DHT’s effects involves caveolae. Western 
blots of whole cell lysates, plasma membranes and plasma membrane fraction 3 
confirmed the presence of caveolin-1 (Figure 5.3A). After DHT treatment for 9 minutes, 
the level of AR in the plasma membrane was reduced and AR was concentrated instead 
in fraction 3 (Figure 5.3B), indicating translocation to caveolae is required. Treatment of 
rat resting zone chondrocytes with 5mM β-CD abrogated the DHT-dependent increase in 
PKC (Figure 5.3C), supporting the hypothesis that lipid rafts and/or caveolae play a role. 
Palmitoylation was required for localization of AR to the membrane.  Tunicamycin 
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(30µM) was able to completely abolish the effect of DHT on PKC activity (Figure 5.3D). 
However, localization of AR in caveolae did not involve myristylation, as HMA had no 
effect (Figure 5.3E). 
 
 
Figure 5.3. Subcellular localization of AR in male resting zone chondrocytes. Male 
resting chondrocytes were treated for 9 minutes ± 10
-7
 M DHT. Whole cell lysates 
(WCL), plasma membranes (PM), and plasma membrane fraction 3 (caveolae) were 
isolated and subjected to western blot (A,B). Role of caveolae structure and AR 
palmitoylation on DHT-mediated PKC activity in male resting zone chondrocytes. 
Cultures were pre-incubated for 30 minutes with 5mM methyl-β-cyclodextrin (β-CD); 
then cells were treated for 9 minutes with 10
-7
 M DHT(C). Cultures were pre-incubated 
for 2 hours with 30µM tunicamycin (D), or 0.5mM 2-hydroxymyristic acid (E). Then 
cells were treated for 9 minutes with 10
-7
 M DHT. PKC specific activity was measured in 
cell layer lysates. Values are the mean± SEM for six independent cultures for each 
variable. *P<0.05, treatment vs. control, ^P<0.05, DHT+ β-CD or DHT+ tunicamycin vs. 
DHT alone for each specific experiment. 
 
Chondrocytes treated with DHT exhibited increased [
35
S]-sulfate incorporation in 
a dose dependent manner (Figure 5.4A). This was mediated by the AR, as the AR-




S]-sulfate incorporation required PLC since inhibition of PI-PLC with U73122 blocked 
the DHT-dependent increase (Figure 5.4C). 
 
 
Figure 5.4: DHT increases maturation in resting zone chondrocytes. Chondrocyte 
maturation was determined by measuring [
35
S]-incorporation. Male rat resting zone 




M DHT alone (A) or cells were 
pre-incubated for 30 minutes with 10
-5
 M U73122 to inhibit PLC (B) or for 30 minutes 
with 10
-5
 M Casodex (C). Cells were then treated for 9 minutes with 10
-7
 M DHT. Media 
were removed and fresh media were added for 24 hours. Four hours prior to the harvest, 
cells were labeled with [
35
S]-sulfate.  At harvest, the conditioned media were removed, 
the cell layers (cells and matrix) were collected, and the amount of [
35
S]-sulfate 
incorporated determined as a function of protein in the cell layer. Data are the mean ± 
SEM for six independent cultures from one representative experiment. *P<0.05, 
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treatment vs. control. ^P<0.05, DHT+ U73122 vs. DHT alone or DHT + Casodex vs. 
DHT alone for each experiment. 
 
Discussion 
 Our previous studies demonstrated that DHT can rapidly activate PKC via a 
pathway that involves G-protein-dependent PI-PLC only in male chondrocytes. However, 
the actual receptors that mediate DHT-stimulated PKC were not determined. That the 
effect of DHT is receptor mediated was demonstrated in the present study by the fact that 
only DHT but not ent-DHT increased PKC activity. Because enantiomers are structural 
mirror images with identical physicochemical properties and receptors have well-defined 
and structurally discriminate binding pockets, they can generally identify specific ligands 
of different absolute configurations. In contrast, membrane lipids present a dynamic 
environment that does not maintain structurally well-defined binding sites for steroids 
[102]. Thus, the difference in the effect of each enantiomer (DHT and ent-DHT) on the 
cell response implies that the binding affinity of DHT to the specific receptor is more 
effective than its enantiomer (ent-DHT). 
 Our results demonstrate that both ERα and ERβ are involved in mediating the 
rapid membrane-associated effects of DHT on the PKC signaling pathway.  Antibodies 
specific for ERα and ERβ blocked the stimulatory effects of DHT on PKC activity. ERα 
[105] and ERβ [106], as well as truncated forms of both receptors are present in the 
plasma membrane [107, 108] and caveolae [109, 110], implying that membrane forms of 
these receptors may play a role in mediating rapid responses to the hormone via caveolae-
dependent mechanisms. This is supported by the observation that destruction of caveolae 
with β-CD blocked the stimulatory effect of DHT on PKC. 
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 Further evidence for the role of caveolae in mediating the effects of DHT on 
PKC, is translocation of the AR to this specialized membrane domain in response to the 
hormones. ARs do not display an intrinsic transmembrane domain [219]; thus an 
interaction of ARs with specific membrane proteins has been proposed to explain their 
membrane localization [219, 220]. The AR has been shown to interact with caveolin-1 in 
other systems [221]. We did not address this specifically but our finding supports this 
hypothesis. Caveolin-1 exists primarily in fraction 3 of the plasma membrane and AR 
was present in fraction 3 only after treatment with DHT.  
 We found that posttranslational palmitoylation is required for AR membrane 
localization and for DHT-induced recruitment of ARs to caveolae. It is possible that by 
palmitoylation, ARs are dynamically recruited from the cytoplasmic pool to the plasma 
membrane and specifically to caveolae, which contain other signaling molecules 
including G-protein α-subunits, kinases, and caveolins [114]. Palmitoylation seems to be 
a common regulatory mechanism in the formation of membrane-associated signaling 
complexes. The interaction between palmitoylated ARs and other caveolae proteins may 
act as a signal for the directional recruitment and restructuring of the receptor. .  
 This study demonstrates that DHT signaling via the AR plays a role in 
chondrocyte maturation by increasing [
35
S]-sulfate incorporation, suggesting an increase 
in the synthesis of a sulfated proteoglycan extracellular matrix. Alkaline phosphatase 
specific activity also increased [23], supporting the hypothesis that the chondrocytes 
produce a mature matrix containing alkaline phosphatase-rich extracellular matrix 
vesicles [222] in response to DHT.  Importantly, our data demonstrate that this effect of 
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DHT is mediated by AR-dependent signaling. It was blocked by AR antagonist, Casodex 











































CONCLUSIONS AND FUTURE PERSPECTIVES 
 
            Our studies show that female growth plate resting zone chondrocytes respond to 
estrogen with an increase in both PKC and PLA2 activities via ERα and ERβ. That the 
effect of E2 is specific and receptor mediated was demonstrated by the fact that only E2 
but not ent-E2 had an effect on PKC activation. Because enantiomers are structural mirror 
images with identical physicochemical properties and receptors have well-defined and 
structurally discriminate binding pockets, they can generally identify specific ligands of 
different absolute configurations. In contrast, membrane lipids present a dynamic 
environment that does not maintain structurally well-defined binding sites for steroids 
[102]. Thus, the difference in the effect of each enantiomer (E2 and ent-E2) on the cell 
response implies that the binding affinity of E2 to the specific receptor is more effective 
than its enantiomer (ent-E2). This supports our previous work showing that the 
stimulatory effect of E2 on PKC signaling is stereospecific [61, 67].  
 Our results demonstrate that both ERα and ERβ are involved in mediating the 
rapid membrane-associated effects of E2 on PKC and PLA2 signaling pathways.  
Antibodies specific for ERα and ERβ blocked the stimulatory effects of E2 on both 
enzymes. In addition, specific agonists for ERβ and ERα stimulated PKC with dose-
response and time course comparable to that of E2.  R,R-THC, which is an agonist for 
ERα and an antagonist for ERβ had no effect on PKC, further supporting the requirement 
for both receptors.   
 The observation that E2 treatment resulted in co-immunoprecipitation of 
ERα/ERβ, suggests that a complex is formed.  We did not test whether such a complex is 
 78 
required for membrane associated signal transduction to occur, but the fact that antibody-
blocking of selective agonists for each receptor blocked the effect of E2 is strong 
presumptive evidence that this is the case.  These results support previous studies showed 
that ER dimerization promotes selective G-protein activation and the loss of the dimer 
fails to provide the structural contact points for G-proteins to bind in an active 
conformation, thus impairing signaling to adenylate cyclase [103]. ERs have also been 
shown to form a complex with androgen receptor in response to treatment with E2 or 
dihydrotestosterone [104].   
 ERα [105] and ERβ [106], as well as truncated forms of both receptors are present 
in the plasma membrane [107, 108] and caveolae [109, 110], implying that membrane 
forms of these receptors may play a role in mediating rapid responses to the hormone. We 
did not address this hypothesis directly in the present study since the 
immunoprecipitation studies were performed using cell lysates and not isolated plasma 
membranes.  However, our results do show that palmitoylation is required for rapid 
activation of PKC by E2, indicating that receptor recruitment to the membrane is involved 
[111, 112]. In contrast, inhibition of myristylation had no effect on E2-dependent PKC 
activitation, indicating that the ERs responsible for mediating the hormone’s effect were 
not integral to the plasma membrane via this mechanism [113].   
            ERs do not display an intrinsic transmembrane domain [76]; thus an interaction of 
ERs with specific membrane protein has been proposed to explain their membrane 
localization [77, 78]. The interaction between ERs caveolin-1 and palmitoylation of ERs 
are the major determinants for the residence of ERs at the plasma membrane [79-81]. In 
this study, we found that posttranslational palmitoylation is required for ER membrane 
 79 
localization and for E2-induced recruitment of ERs to the plasma membrane. It is possible 
that by palmitoylation, ERs are dynamically recruited from the cytoplasmic pool to the 
plasma membrane and most likely to the caveolae, which contains other signaling 
molecules including G-protein α-subunits, kinases, and caveolins [114]. The interaction 
between palmitoylated ERs and other caveolae proteins may act as a signal for the 
directional recruitment and restructuring of the receptor. Consequently, ERs were able to 
mediate further stimulation of PKC activity at 90 minutes. Thus, palmitoylation seems to 
be a common regulatory mechanism in the formation of membrane-associated signaling 
complexes [115]. This study provides evidence that the sex-specific difference in E2-
dependent membrane-associated signaling male and female growth plate chondrocytes is 
due to differential regulation of ER isoforms in the plasma membrane and specifically, in 
the caveolae.  Whereas plasma membranes and caveolae isolated from female cells 
possess ERα68, ERα46 and ERα36 as well as ERβ59, plasma membranes from male cells 
lack ERα36.  Moreover, caveolae from male cells lack both ERα36 and ERβ59.  
Caveolae are critical to the ability of E2 to activate rapid PKC signaling in the female 
cells, as evidence by the loss of an E2 effect when caveolae were disrupted by treatment 
with β-cyclodextrin.   
We did not specifically knockdown ERα36 or ERβ59, but our results strongly 
implicate both receptors in the failure of male cells to respond to E2.  Male caveolae lack 
both isoforms but possess ERα68 and ERα46.  Although agonists for both ERα and ERβ 
activated PKC in female chondrocytes, neither agonist was able to do so in male 
chondrocytes, despite the presence of two ERα isoforms as well as evidence components 
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of the signaling pathways involved in PKC activation were present and could be 
stimulated to the same extent as in female cells.   
ER trafficking may be an important variable in the differential response of male 
and female chondrocytes to E2 as well.  Others have shown that palmitoylation is 
required for the plasma membrane association of ERs [25, 113].  This was the case for 
female chondrocytes in the present study. E2 increased the association of ERs with the 
plasma membrane, particularly ERα46, ERα36 and ERβ59 whereas tunicamycin reduced 
the association of all three ERα isoforms and ERβ59 with the plasma membrane.  In male 
cells, however, E2 caused a marked reduction in the association of ERα68, ERα46 and 
ERβ59 with the plasma membrane.  Why the receptor trafficking in the male cells was 
contra to that of the female cells is not clear.  In female cells, E2 elicits formation of a 
multi-receptor complex that involves both ERα and ERβ, but this is not the case for male 
cells, suggesting that a scaffolding unit may be absent.  In other studies, caveolin-1 
provides scaffolding for ER translocation to the plasma membrane [72, 218, 223] and 
palmitoylation is required for caveolin-1 to interact with the plasma membrane [224]. 
This suggests that a difference between male and female cells may be related to the 
palmitoylation mechanism.  It is also possible that E2 treatment in male cells may lead to 
ER translocation to the nucleus. 
Our results confirm our previous study that female cells have more ERs than male 
cells [129] and show that it is specifically the pool of ERs that are on the surface of the 
cell that contribute to this increase. The percentage of positive female cells was not 
significantly different than the percentage of positive male cells in non-permeabilized 
cells, although the total number of ERα on the surface was significantly higher in female 
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cells.  This is in agreement with our previous study, which showed that there was no 
difference in E2-binding affinity between females and males, but females had more 
receptors [129]. No differences in total ERα number were found when assessing ERα 
content of permeabilized cells whereas ERα content of non-permeabilized cells, i.e., the 
cell surface, was more than two times greater in female cells.  This is an important 
observation given the fact that ERα36 was present only on the plasma membranes of 
female cells, whereas all other isoforms of ERα as well as ERβ59 were present on the 
plasma membranes of male cells.  While this strongly supports the hypothesis that ERα36 
plays a critical role, it is not yet definitive proof.  However, recent studies in our lab 
examining the role of ERα36 in E2 dependent activation of PKC in breast cancer cells 
showed that specific antibodies to this isoform blocked the stimulatory effect of the 
hormone [211]. 
E2 activates PKC in growth plate chondrocytes occurs via two signaling 
pathways, PLC and PLA2.  Our results indicate that the failure of male cells to respond to 
E2 is not due to an intrinsic defect in either pathway.  Activation of PLC m-3M3FβS 
could be achieved to the same extent in male and female cells.  Similarly, both male and 
female cells were capable of generating PGE2 when PLAA was used to activate PLA2.  
The effect of PLAA was less robust in male cells, raising the possibility that the PLA2 
pathway was reduced in some manner, but it is difficult to draw too many conclusions 
given the fact that PGE2 production is a downstream surrogate for the enzyme itself.  
These data do show that the difference in response occurs upstream from the enzymes 
triggering the signaling pathways and support the conclusion that the difference is at the 
receptor level. 
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This study demonstrates that DHT regulates growth plate chondrocytes in a sex-
specific manner via rapid signaling pathways. The effects of DHT were observed only in 
chondrocytes from male rat growth plates and occurred within 9 minutes.  Both PKC and 
PLA2 were activated in a dose-dependent manner and increases in activity were seen at 
physiologically relevant concentrations. No effect of the testosterone metabolite was 
observed in the female cells. Moreover, the results show that the stimulatory effects on 
these two signaling pathways were specific to DHT and not testosterone as testosterone 
had no effect on either enzyme activity. 
           Neither gene transcription nor translation were required for DHT-dependent PKC 
activation to occur, indicating that DHT stimulated existing enzyme. We did not 
determine which PKC isoform was sensitive to DHT, but the assay conditions that were 
used are optimized to isoforms sensitive to both Ca
2+
 ions and phospholipids, suggesting 
a role for PKCα in the mechanism [196, 197].  
 CPA, which competes with testosterone and DHT to bind to the androgen 
receptor, did not inhibit the rapid responses, suggesting that DHT regulates PKC via a 
specific receptor that is different than the classic nuclear receptor. T-BSA which can not 
enter the cell, also failed to activate PKC, indicating that testosterone dose not participate 
via a membrane form of AR and suggesting that DHT’s effect is also via membrane AR.  
It is likely that the DHT-receptor is membrane-associated, however, as DHT stimulated 
PKC by mechanisms that are membrane-mediated.  
The DHT-receptor might be a G-protein coupled receptor, as our results showed 
that G-protein is required for DHT-dependent PKC activation. There are two classes of 
G-proteins that couple receptors to the activation of PI-PLC: one that is PTX-sensitive 
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and one that is PTX-insensitive [198]. Pre-incubation of chondrocytes with both PTX 
(Gαi inhibitor) and CTX (Gαs activator) completely blocked the stimulatory effect of 
DHT on PKC activity. In other systems, upon G-protein activation, Gα disassociates from 
Gβγ, which can then activate Ca
2+
 ion channels on the plasma membrane [199]. Our 
results show that DHT stimulates influx of extracellular Ca
2+ 
ions. Moreover, inhibition 
of Ca
2+ 
influx blocks the stimulatory effect of DHT on PKC. Gα proteins have also been 
shown to activate PI-PLC [200],[201] and PLC was required for DHT-dependent PKC 
activation, since specific inhibition of PI-PLC blocked activation of PKC by DHT. 
Moreover, inhibition of release of Ca
2+
 ions from the endoplasmic reticulum also reduced 
DHT‘s effect. PI-PLC catalyzes the release of IP3, which opens these Ca
2+ 
ion channels 
and resulting DAG translocates the active PKC to the plasma membrane. Although Gαq 
is generally associated with PI-PLC activation [202], Gαi has also been shown to do so 
[182].  
 It is also possible that Gαi is activating PLA2, and that is upstream of PI-PLC, as 
we have shown for 1α,25-dihydroxy vitamin D3–dependent activation of PKC in growth 
plate chondrocytes [203]. Our results show that DHT activated PKC via a PLA2-
dependent pathway. DHT caused a rapid increase in PLA2 activity and inhibition of 
PLA2 blocked the stimulatory effect of DHT on PKC. Production of lysophospholipid 
[204] and release of arachidonic acid [205] are catalyzed by PLA2 via phospholipid 
hydrolysis. Arachidonic acid can act as co-factor for PKCα and also provides a substrate 
for constitutively active cyclooygenase-1 (Cox-1) in growth plate chondrocytes, which 
leads to prostaglandin production. In addition, lysophospholipid can activate PLC [203], 
and can then initiate the downstream PLC-PKC pathway  
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 Our results demonstrate that DHT regulates proliferation and differentiation of 
growth plate chondrocytes by multiple mechanisms. The fact that U73122 blocked the 
stimulatory effect of DHT on alkaline phosphatase activity suggests that rapid membrane 
response via the PLC-PKC pathway plays an important role in differentiation of male 
chondrocytes. In contrast, DNA synthesis is not regulated in this manner.  We previously 
showed that testosterone and DHT can regulate proliferation [33]; however, in the present 
study, a 9 minute pulse of DHT had no effect on [
3
H]-thymidine incorporation, indicating 
that the proliferative effects of testosterone and/or DHT are likely mediated by the classic 
androgen receptor.  
 Rat growth plate chondrocytes possess 5α-reductase and convert testosterone to 
DHT [33, 172], and regulation of these cells by testosterone is dependent on the 
production and release of DHT [172]. Here we show that DHT but not testosterone elicits 
the rapid membrane response. Taken together, this suggests that the membrane-associated 
effects of androgens are mediated by paracrine actions of DHT.  
 In summary, DHT regulates male resting zone chondrocytes through rapid 
activation of a membrane-associated receptor. This results in PLA2 and PLC-mediated 
activation of PKC and increase in chondrocyte differentiation. These findings indicate the 
importance of the membrane effects as mediators of DHT action in chondrocytes and 
suggest the existence of a specific membrane receptor for DHT in chondrocytes. 
 
 
This work has established the membrane receptors involved in 17β-estradiol (E2) 
and dihydrotestosterone sexual-dimorphic effect on longitudinal bone growth. 
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Additionally we were able to identify and understand the non-traditional steroid signaling 
mechanism. Moreover, it may lead to design compounds that only activate the membrane 
steroid receptors and not the traditional cytoplasmic receptors. This could be very 
beneficial for the treatment of postmenopausal osteoarthritis and osteoporosis while not 
increasing the risks commonly associated with hormone replacement therapy like 
increased incidence of breast and ovarian cancers. However, there are still numerous 
unanswered questions regarding sexual dimorphism and cartilage regeneration.  
The most important next step is applying our finding on in vivo studies to determine what 
role E2 and DHT   could have on in vivo tissue formation. It would also be of interest to 
investigate if this sex-specific E2 membrane effect was present in all tissues including 
other types of cartilage like elastic auricular tissue or intervertebral discs. Perhaps 
different tissues express variable concentrations and isoforms of sex steroid membrane 
receptors that control their sexual dimorphism. If this is the case, then the development of 
drugs that are more beneficial for only men or women may be a reality in the future.  
Our previous studies demonstrated that DHT can rapidly activate PKC via a 
pathway that involves G-protein-dependent PI-PLC only in male chondrocytes. However, 
the actual receptors that mediate DHT-stimulated PKC were not determined. That the 
effect of DHT is receptor mediated was demonstrated in the present study by the fact that 
only DHT but not ent-DHT increased PKC activity. Because enantiomers are structural 
mirror images with identical physicochemical properties and receptors have well-defined 
and structurally discriminate binding pockets, they can generally identify specific ligands 
of different absolute configurations. In contrast, membrane lipids present a dynamic 
environment that does not maintain structurally well-defined binding sites for steroids 
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[102]. Thus, the difference in the effect of each enantiomer (DHT and ent-DHT) on the 
cell response implies that the binding affinity of DHT to the specific receptor is more 
effective than its enantiomer (ent-DHT). 
 Our results demonstrate that both ERα and ERβ are involved in mediating the 
rapid membrane-associated effects of DHT on the PKC signaling pathway.  Antibodies 
specific for ERα and ERβ blocked the stimulatory effects of DHT on PKC activity. ERα 
[105] and ERβ [106], as well as truncated forms of both receptors are present in the 
plasma membrane [107, 108] and caveolae [109, 110], implying that membrane forms of 
these receptors may play a role in mediating rapid responses to the hormone via caveolae-
dependent mechanisms. This is supported by the observation that destruction of caveolae 
with β-CD blocked the stimulatory effect of DHT on PKC. 
 Further evidence for the role of caveolae in mediating the effects of DHT on 
PKC, is translocation of the AR to this specialized membrane domain in response to the 
hormones. ARs do not display an intrinsic transmembrane domain [219]; thus an 
interaction of ARs with specific membrane proteins has been proposed to explain their 
membrane localization [219, 220]. The AR has been shown to interact with caveolin-1 in 
other systems [221]. We did not address this specifically but our finding supports this 
hypothesis. Caveolin-1 exists primarily in fraction 3 of the plasma membrane and AR 
was present in fraction 3 only after treatment with DHT.  
 We found that posttranslational palmitoylation is required for AR membrane 
localization and for DHT-induced recruitment of ARs to caveolae. It is possible that by 
palmitoylation, ARs are dynamically recruited from the cytoplasmic pool to the plasma 
membrane and specifically to caveolae, which contain other signaling molecules 
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including G-protein α-subunits, kinases, and caveolins [114]. Palmitoylation seems to be 
a common regulatory mechanism in the formation of membrane-associated signaling 
complexes. The interaction between palmitoylated ARs and other caveolae proteins may 
act as a signal for the directional recruitment and restructuring of the receptor. .  
 This study demonstrates that DHT signaling via the AR plays a role in 
chondrocyte maturation by increasing [
35
S]-sulfate incorporation, suggesting an increase 
in the synthesis of a sulfated proteoglycan extracellular matrix. Alkaline phosphatase 
specific activity also increased [23], supporting the hypothesis that the chondrocytes 
produce a mature matrix containing alkaline phosphatase-rich extracellular matrix 
vesicles [222] in response to DHT.  Importantly, our data demonstrate that this effect of 
DHT is mediated by AR-dependent signaling. It was blocked by AR antagonist, Casodex 
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